DIONEX CORP /DE
DEF 14A, 1997-09-12
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Previous: MERRIMAC INDUSTRIES INC, SC 13D/A, 1997-09-12
Next: METROPOLITAN SERIES FUND INC, 497, 1997-09-12



                            SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
                                (Amendment No. )

Filed by the Registrant
Filed by a Party other than the Registrant        |_|

Check the appropriate box:

|_|  Preliminary Proxy Statement

|_|  Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule
     14a-6(e)(2)) 
     
|X|  Definitive Proxy Statement

|_|  Definitive Additional Materials

|_|  Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

                               DIONEX CORPORATION
                (Name of Registrant as Specified In Its Charter)

     (Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box)

     No fee required.
|_|  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     1.        Title of each class of securities to which transaction applies:

        ------------------------------------------------------------------------
     2.        Aggregate number of securities to which transaction applies:

        ------------------------------------------------------------------------

     3.        Per unit price or other underlying value of transaction  computed
          pursuant to Exchange  Act Rule 0-11 (Set forth the amount on which the
          filing fee is calculated and state how it was determined):

        ------------------------------------------------------------------------

     4.        Proposed maximum aggregate value of transaction:

        ------------------------------------------------------------------------

     5.        Total fee paid:

        ------------------------------------------------------------------------

|_|  Fee paid previously with preliminary materials.

|_|  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the filing for which the  offsetting  fee was paid
     previously.  Identify the previous filing by registration statement number,
     or the Form or Schedule and the date of its filing.

     1    Amount Previously Paid:_______________________________________________
     2    Form, Schedule or Registration Statement No.:_________________________
     3    Filing Party:_________________________________________________________
     4    Date Filed:___________________________________________________________

     5    


<PAGE>

                               DIONEX CORPORATION
                                501 Mercury Drive
                           Sunnyvale, California 94086

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
                         TO BE HELD ON OCTOBER 23, 1997

TO THE STOCKHOLDERS OF DIONEX CORPORATION:

     NOTICE IS HEREBY GIVEN that the Annual  Meeting of  Stockholders  of Dionex
Corporation,  a Delaware  corporation  (the  "Company"),  will be held at Dionex
Corporation,  501 Mercury  Drive,  Sunnyvale,  California  94086,  on  Thursday,
October 23, 1997 at 9:00 a.m. for the following purposes:

     1 To elect  directors  to  serve  for the  ensuing  year  and  until  their
successors are elected.

     2 To approve an  amendment to the Dionex  Corporation  Stock Option Plan to
increase the aggregate  number of shares of Common Stock authorized for issuance
under such plan by 400,000 shares.

     3 To approve an amendment to the 1988 Directors Stock Option Plan to extend
the  term of the  plan to  July  27,  2007  and to make  certain  administrative
changes.

     4 To  ratify  the  selection  of  Deloitte  & Touche  LLP as the  Company's
independent auditors for its fiscal year ending June 30, 1998.

     5 To transact  such other  business as may properly come before the meeting
or any adjournment or postponement thereof.

     The  foregoing  items of  business  are more fully  described  in the Proxy
Statement accompanying this Notice.

     The Board of Directors has fixed the close of business on September 8, 1997
as the record date for the  determination of stockholders  entitled to notice of
and to  vote at this  Annual  Meeting  and at any  adjournment  or  postponement
thereof.

                                              BY ORDER OF THE BOARD OF DIRECTORS


                                              JAMES C. GAITHER
                                              Secretary

Sunnyvale, California
September 12, 1997

     ALL  STOCKHOLDERS  ARE  CORDIALLY  INVITED TO ATTEND THE MEETING IN PERSON.
WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE, SIGN AND
RETURN THE  ENCLOSED  PROXY AS  PROMPTLY  AS  POSSIBLE  IN ORDER TO ENSURE  YOUR
REPRESENTATION  AT THE MEETING.  A RETURN  ENVELOPE (WHICH IS POSTAGE PREPAID IF
MAILED IN THE UNITED  STATES) IS  ENCLOSED  FOR THAT  PURPOSE.  EVEN IF YOU HAVE
GIVEN YOUR PROXY, YOU MAY STILL VOTE IN PERSON IF YOU ATTEND THE MEETING. PLEASE
NOTE, HOWEVER, THAT IF YOUR SHARES ARE HELD OF RECORD BY A BROKER, BANK OR OTHER
NOMINEE  AND YOU WISH TO VOTE AT THE  MEETING,  YOU MUST BRING TO THE  MEETING A
LETTER  FROM  THE  BROKER,  BANK OR OTHER  NOMINEE  CONFIRMING  YOUR  BENEFICIAL
OWNERSHIP OF THE SHARES. ADDITIONALLY, IN ORDER TO VOTE AT THE MEETING, YOU MUST
OBTAIN FROM THE RECORD HOLDER A PROXY ISSUED IN YOUR NAME.



<PAGE>


                               DIONEX CORPORATION
                                501 Mercury Drive
                           Sunnyvale, California 94086

                              1997 Proxy Statement
                 Information Concerning Solicitation and Voting

General

     The enclosed  proxy is solicited on behalf of the Board of Directors of the
Company (the "Board") for use at the Annual Meeting of  Stockholders  to be held
on October 23, 1997, at 9:00 a.m. (the "Annual Meeting"),  or at any adjournment
or  postponement  thereof,  for  the  purposes  set  forth  herein  and  in  the
accompanying Notice of Annual Meeting. The Annual Meeting will be held at Dionex
Corporation, 501 Mercury Drive, Sunnyvale, California 94086.

Solicitation

     The Company will bear the entire cost of solicitation of proxies, including
preparation,  assembly,  printing and mailing of this proxy statement, the proxy
and any additional information furnished to stockholders. Copies of solicitation
materials  will  be  furnished  to  banks,  brokerage  houses,  fiduciaries  and
custodians  holding in their names shares of Common Stock  beneficially owned by
others to forward to such beneficial  owners.  The Company may reimburse persons
representing  beneficial  owners of Common  Stock for their costs of  forwarding
solicitation  materials to such  beneficial  owners.  Original  solicitation  of
proxies  by  mail  may  be  supplemented  by  telephone,  telegram  or  personal
solicitation by directors,  officers or other regular  employees of the Company.
No additional compensation will be paid to directors,  officers or other regular
employees for such services.

     The Company  intends to mail this proxy  statement and  accompanying  proxy
card on or about September 12, 1997, to all stockholders entitled to vote at the
Annual Meeting.

Voting Rights and Outstanding Shares

     Only  holders  of  record  of  Common  Stock at the  close of  business  on
September  8, 1997  will be  entitled  to  notice  of and to vote at the  Annual
Meeting.  At the close of  business  on  September  8,  1997,  the  Company  had
outstanding and entitled to vote 11,686,011  shares of Common Stock. Each holder
of  record of Common  Stock on such date will be  entitled  to one vote for each
share held on all matters to be voted upon at the Annual Meeting.

     All votes will be tabulated by the inspector of election  appointed for the
meeting,   who  will  separately   tabulate   affirmative  and  negative  votes,
abstentions  and  broker  non-votes.  Abstentions  will be counted  towards  the
tabulation  of votes cast on proposals  presented to the  stockholders  and will
have the same effect as negative votes.  Broker  non-votes are counted towards a
quorum, but are not counted for any purpose in determining  whether a matter has
been approved.

Revocability of Proxies

     Any person giving a proxy  pursuant to this  solicitation  has the power to
revoke it at any time  before it is voted.  It may be revoked by filing with the
Secretary  of the  Company at the  Company's  principal  executive  office,  501
Mercury Drive, Sunnyvale,  California 94086, a written notice of revocation or a
duly executed  proxy bearing a later date, or it may be revoked by attending the
meeting and voting in person.  Attendance  at the  meeting  will not, by itself,
revoke a proxy.


<PAGE>


                                   PROPOSAL 1

                              ELECTION OF DIRECTORS

     There are four nominees for the four Board positions  presently  authorized
in the Company's By-laws. Each director to be elected will hold office until the
next annual meeting of  stockholders  and until his successor is elected and has
qualified, or until such director's earlier death,  resignation or removal. Each
nominee listed below is currently a director of the Company,  all four directors
having been elected by the stockholders.

     Shares represented by executed proxies will be voted, if authority to do so
is not withheld, for the election of the four nominees named below. In the event
that any nominee should be unavailable for election as a result of an unexpected
occurrence,  such  shares  will be voted  for the  election  of such  substitute
nominee as management may propose. Each person nominated for election has agreed
to serve if elected,  and  management  has no reason to believe that any nominee
will be unable to serve.  Directors  are elected by a plurality  of the votes of
the  holders  of Common  Stock  present  in person or  represented  by proxy and
entitled to vote.

    THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF EACH NAMED NOMINEE.

Nominees

     The  following  information  pertains  to  the  nominees,  their  principal
occupations for the preceding five-year period, certain directorships, and their
ages as of August 31, 1997.

                                          Principal Occupation/ Positions
  Name                             Age    Held with the Company
  ----                             ---    ---------------------

  David L. Anderson.............    53    General Partner, Sutter Hill Ventures
  James F. Battey...............    76    Independent Investor
  A. Blaine Bowman..............    51    President and Chief Executive Officer
  B. J. Moore...................    61    Management Consultant

     Mr. Anderson has been a general partner of Sutter Hill Ventures,  a venture
capital  investment  partnership,  since  1974.  Mr.  Anderson  has  served as a
director of Dionex  Corporation since it began operations in 1980 and previously
served as a director of the predecessor of Dionex  Corporation.  Mr. Anderson is
also a director of Cytel Corporation, Neurex Corporation,  BroadVision, Inc. and
Molecular Devices Corporation.

     Dr.  Battey was President and Chief  Executive  Officer of Psi Star,  Inc.,
which manufactured  equipment used in the production of computer circuit boards,
from 1981 until May 1987,  and  Chairman  of the Board of Psi Star from May 1987
until his  retirement in May 1990. Dr. Battey has served as a director of Dionex
Corporation  since  it  began  operations  in 1980 and  previously  served  as a
director of the predecessor of Dionex Corporation.

     Mr.  Bowman  has  served as the  Company's  President  and Chief  Executive
Officer and as a director since the Company began operations in 1980. Mr. Bowman
is also a director of Molecular Devices Corporation.

     Mr. Moore is an independent management consultant. From December 1985 until
July  1991,  he was  President  of  Outlook  Technology,  Inc.,  a company  that
manufactured  and sold high  performance  instrumentation  and was  merged  with
Biomation  Corporation  in August  1991.  He has served as a director  of Dionex
Corporation  since  it  began  operations  in 1980 and  previously  served  as a
director of the predecessor of Dionex Corporation.  Mr. Moore is also a director
of Adaptec, Inc.



                                       2.
<PAGE>


Meetings; Committees

     During the fiscal year ended June 30,  1997,  the Board held six  meetings.
The Board has two committees,  an Audit Committee and a Compensation  Committee.
The Audit Committee recommends engagement of the Company's independent auditors,
approves  services  performed by such  auditors,  and reviews and  evaluates the
Company's accounting system and its system of internal accounting controls.  The
Audit  Committee,  consisting  of  Messrs.  Anderson,  Bowman  and Moore and Dr.
Battey, held one meeting during the fiscal year ended June 30, 1997.

     The Compensation  Committee reviews and administers the compensation of the
Company's officers and certain members of senior management of the Company.  The
members of the  Compensation  Committee  are Messrs.  Anderson and Moore and Dr.
Battey.  During the fiscal year ended June 30, 1997, the Compensation  Committee
held two meetings.

     During the fiscal year ended June 30, 1997,  each Board member attended 75%
or more of the  aggregate of the meetings of the Board and the  committees  upon
which such member served.

                                   PROPOSAL 2

            APPROVAL OF INCREASE IN NUMBER OF SHARES OF COMMON STOCK
         ISSUABLE FOR GRANTS UNDER DIONEX CORPORATION STOCK OPTION PLAN

     In July 1997,  the Board  approved an amendment  to the Dionex  Corporation
Stock Option Plan (the "Plan")  increasing  the number of shares of Common Stock
issuable  under the Plan by  400,000  shares.  The Board also  approved  certain
administrative amendments that it deemed advisable as a result of changes in the
securities laws. At June 30, 1997, 711,677 shares (plus any shares that might be
returned  to the Plan as a result of  cancellations  or  expiration  of options)
remained available for future grant under the Plan. During the fiscal year ended
June 30, 1997, the Company granted to all current executive  officers as a group
options to purchase 191,000 shares at an exercise price of $32.625 per share and
to all employees  (excluding  executive officers) as a group options to purchase
167,200 shares at an exercise price of $32.625 per share.

     Stockholders  are requested in Proposal 2 to approve the  amendments to the
Plan.  If the  stockholders  fail to  approve  Proposal  2, the number of shares
available  for  future  grant  under  the  Plan  will  remain  at  711,677.  The
affirmative vote of a majority of the shares present in person or represented by
proxy and  entitled  to vote at the  meeting  will be  required  to approve  the
amendments to the Plan.  Abstentions  will be counted  towards the tabulation of
votes cast on  proposals  presented to the  stockholders  and will have the same
effect as negative votes. Broker non-votes are counted towards a quorum, but are
not  counted  for any  purpose  in  determining  whether  this  matter  has been
approved.

     The essential features of the Plan, as amended, are outlined below:

General

     The Plan provides for the grant of both  incentive and  nonstatutory  stock
options.  Incentive stock options granted under the Plan are intended to qualify
as "incentive  stock options"  within the meaning of Section 422 of the Internal
Revenue  Code of 1986,  as amended  (the  "Code").  Nonstatutory  stock  options
granted  under the Plan are intended not to qualify as incentive  stock  options
under the Code.  See "Federal  Income Tax  Information"  for a discussion of the
federal income tax treatment of incentive and nonstatutory stock options.



                                       3.
<PAGE>

Purpose

     The Plan was  adopted to  provide a means by which  selected  officers  and
employees of and consultants to the Company and its affiliates could be given an
opportunity  to  purchase  stock in the  Company,  to  assist in  retaining  the
services of employees  holding key positions,  to secure and retain the services
of persons capable of filling such positions and to provide  incentives for such
persons to exert maximum efforts for the success of the Company.  As of June 30,
1997,  stock  options have been granted to  approximately  20% of the  Company's
active employees.

Administration

     The Plan is administered by the Board.  The Board has the power to construe
and interpret the Plan and,  subject to the provisions of the Plan, to determine
the persons to whom and the dates on which  options will be granted,  the number
of shares to be subject  to each  option,  the time or times  during the term of
each option within which all or a portion of such option may be  exercised,  the
exercise price,  the type of  consideration  and other terms of the option.  The
Board is  authorized  to  delegate  administration  of the  Plan to a  committee
composed  of not fewer than two  members of the Board.  The Board has  delegated
administration  of the Plan to the Compensation  Committee of the Board. As used
herein  with  respect  to the  Plan,  the  "Board"  refers  to the  Compensation
Committee as well as to the Board itself.

     Pursuant to the Plan,  directors  who serve as members of the  Compensation
Committee  must be  "outside  directors."  This  limitation  excludes  from  the
Compensation  Committee  (i)  current  employees  of the  Company,  (ii)  former
employees of the Company  receiving  compensation  for past services (other than
benefits under a tax-qualified  pension plan), (iii) current and former officers
of the  Company,  and (iv)  directors  currently  receiving  direct or  indirect
remuneration from the Company in any capacity (other than as a director), unless
any such person is otherwise  considered  an "outside  director" for purposes of
Section 162(m) of the Code.

Eligibility

     Incentive  stock options may be granted under the Plan only to selected key
employees (including  officers) of the Company and its affiliates.  Selected key
employees   (including   officers)  and  consultants  are  eligible  to  receive
nonstatutory  stock  options  under the  Plan.  Directors  who are not  salaried
employees of or  consultants  to the Company or to any  affiliate of the Company
are not eligible to participate in the Plan.

     No incentive option may be granted under the Plan to any person who, at the
time of the grant,  owns (or is deemed to own) stock possessing more than 10% of
the total combined  voting power of the Company or any affiliate of the Company,
unless the option  exercise  price is at least 110% of the fair market  value of
the stock subject to the option on the date of grant, and the term of the option
does not exceed five years from the date of grant.  For incentive  stock options
granted under the Plan, the aggregate fair market value,  determined at the time
of grant,  of the shares of Common  Stock with respect to which such options are
exercisable  for the first time by an optionee  during any calendar  year (under
all such plans of the Company and its affiliates) may not exceed $100,000.

     The Plan limits grants to 200,000  shares of Common Stock for each employee
for each  twelve-month  period.  The purpose of this  limitation is generally to
comply with  requirements  for options  granted with an exercise  price at least
equal to fair market  value of the Common  Stock on the date of grant to qualify
as  "performance-based  compensation"  under Code Section 162(m),  such that the
Company may  continue  to be able to deduct for tax  purposes  the  compensation
attributable to the exercise of such options granted under the Plan.

Stock Subject to the Plan

     If options  granted  under the Plan expire or otherwise  terminate  without
being exercised,  the Common Stock not purchased  pursuant to such options again
becomes available for issuance under the Plan.


                                       4.
<PAGE>


Terms of Options

     The following is a description  of the  permissible  terms of options under
the Plan.  Individual  option grants may be more restrictive as to any or all of
the permissible terms described below.

     Exercise  Price;  Payment.  The exercise  price of incentive  stock options
under the Plan may not be less than the fair  market  value of the Common  Stock
subject to the option on the date of the option  grant,  and, in some cases (see
"Eligibility"  above),  may not be less than 110% of such fair market value. The
exercise price of  nonstatutory  options under the Plan may not be less than 85%
of the fair market value of the Common  Stock  subject to the option on the date
of the option grant.  However, if options are granted with exercise prices below
fair market value,  deductions for compensation  attributable to the exercise of
such options could be limited by Code Section  162(m).  See "Federal  Income Tax
Information."  At July 31, 1997, the closing price of the Company's Common Stock
as reported on The Nasdaq National Market was $45.625 per share.

     The exercise  price of options  granted under the Plan must be paid either:
(a) in cash at the time the option is exercised; or (b) at the discretion of the
Board, (i) by delivery of other Common Stock of the Company,  (ii) pursuant to a
deferred payment arrangement;  or (iii) in any other form of legal consideration
acceptable to the Board.

     Option Exercise.  Options granted under the Plan may become  exercisable in
cumulative  increments  ("vest") as determined by the Board.  Shares  covered by
currently  outstanding  options under the Plan  typically vest in 25% increments
each year  beginning  one year from the date of the  grant.  Shares  covered  by
options granted in the future under the Plan may be subject to different vesting
terms. The Board has the power to accelerate the time during which an option may
be exercised.  In addition,  options  granted under the Plan may permit exercise
prior to vesting,  but in such event the  optionee may be required to enter into
an early exercise stock purchase agreement that allows the Company to repurchase
shares not yet vested at their  exercise  price  should the  optionee  leave the
service of the Company before vesting. To the extent provided by the terms of an
option,  an optionee  may satisfy any  federal,  state or local tax  withholding
obligation  relating  to the  exercise  of such  option by a cash  payment  upon
exercise,  by  authorizing  the  Company  to  withhold  a  portion  of the stock
otherwise  issuable to the optionee,  by delivering  already-owned  stock of the
Company or by a combination of these means.

     Term. The maximum term of options under the Plan is ten years,  except that
in certain  cases (see  "Eligibility")  the maximum term is five years.  Options
under the Plan generally  terminate 30 days after  termination of the optionee's
employment  or  relationship  as a consultant of the Company or any affiliate of
the Company,  unless (a) such termination is due to such person's  permanent and
total  disability  (as defined in the Code),  in which case the option may,  but
need not,  provide  that it may be exercised at any time within one year of such
termination;  (b) the optionee dies while employed by or serving as a consultant
or director of the Company or any  affiliate of the  Company,  or within 30 days
after termination of such  relationship,  in which case the option may, but need
not,  provide that it may be exercised (to the extent the option was exercisable
at the time of the optionee's death) within 18 months of the optionee's death by
the person or persons to whom the rights to such  option  pass by will or by the
laws of descent and  distribution;  or (c) the option by its terms  specifically
provides  otherwise.  Individual options by their terms may provide for exercise
within a longer  period  of time  following  termination  of  employment  or the
consulting relationship.  The option term may also be extended in the event that
exercise of the option within these periods is prohibited for specified reasons.


                                       5.


<PAGE>


Adjustment Provisions

     If there is any  change in the stock  subject to the Plan or subject to any
option granted under the Plan (through  merger,  consolidation,  reorganization,
recapitalization,  stock dividend,  dividend in property other than cash,  stock
split,  liquidating dividend,  combination of shares, exchange of shares, change
in  corporate  structure  or  otherwise),   the  Plan  and  options  outstanding
thereunder will be appropriately adjusted as to the class and the maximum number
of shares  subject  to such  plan,  the  maximum  number of shares  which may be
granted to an optionee during any twelve-month  period, and the class, number of
shares and price per share of stock subject to such outstanding options.

Effect of Certain Corporate Events

     The Plan provides that, in the event of a dissolution or liquidation of the
Company,  specified  type of merger or other  corporate  reorganization,  to the
extent  permitted by law, any surviving  corporation  will be required to either
assume  options  outstanding  under the Plan or substitute  similar  options for
those outstanding under such plan, or such outstanding  options will continue in
full force and effect. In the event that any surviving  corporation  declines to
assume or continue options  outstanding under the Plan, or to substitute similar
options,  then the time  during  which such  options  may be  exercised  will be
accelerated  and the options  terminated if not exercised  during such time. The
acceleration  of an option in the event of an acquisition  or similar  corporate
event may be viewed as an antitakeover  provision,  which may have the effect of
discouraging a proposal to acquire or otherwise obtain control of the Company.

Duration, Amendment and Termination

     The Board may suspend or terminate the Plan without stockholder approval or
ratification at any time or from time to time.  Excluding any such action by the
Board, the Plan will terminate on July 26, 2005.

     The  Board  may  also  amend  the  Plan at any  time or from  time to time.
However,  no amendment will be effective  unless approved by the stockholders of
the Company if the amendment requires  stockholder  approval in order to satisfy
the  requirements  of Section 422 of the Code or Rule 16b-3 under the Securities
Exchane Act of 1934, as amended (the "Exchange  Act").  The Board may submit any
other amendment to the Plan for stockholder approval, including, but not limited
to,  amendments  intended to satisfy the  requirements  of Section 162(m) of the
Code  regarding  the  exclusion  of  performance-based   compensation  from  the
limitation on the deductibility of compensation to certain employees.

Restrictions on Transfer

     Under the Plan,  an incentive  stock option may not be  transferred  by the
optionee  other than by will or by the laws of  descent  and  distribution,  and
during the lifetime of the optionee,  may be exercised  only by the optionee.  A
nonstatutory  stock option may not be transferred  except by will or by the laws
of descent and distribution or under certain other limited circumstances. In any
case,  the optionee may  designate in writing a third party who may exercise the
option in the event of the  optionee's  death.  In addition,  shares  subject to
repurchase by the Company under an early exercise  stock purchase  agreement may
be subject to restrictions on transfer as the Board deems appropriate.

Federal Income Tax Information

     Incentive  Stock  Options.  Incentive  stock  options  under  the  Plan are
intended to be eligible for the favorable federal income tax treatment  accorded
"incentive stock options" under the Code.

     There  generally are no federal income tax  consequences to the optionee or
the  Company by reason of the grant or exercise of an  incentive  stock  option.
However,  the  exercise of an  incentive  stock  option may cause an optionee to
become  subject to the  alternative  minimum tax or result in an increase in the
optionee's alternative


                                       6.
<PAGE>


minimum tax liability.

     If an optionee holds stock acquired  through exercise of an incentive stock
option for at least two years  from the date on which the option is granted  and
at least one year  from the date on which  the  shares  are  transferred  to the
optionee upon exercise of the option,  any gain or loss on a disposition of such
stock will be capital gain or loss.  Generally,  if the optionee disposes of the
stock before the expiration of either of these holding periods (a "disqualifying
disposition"),  at the time of  disposition,  the optionee will realize  taxable
ordinary income equal to the lesser of (a) the excess of the stock's fair market
value on the date of exercise  over the exercise  price,  or (b) the  optionee's
actual gain, if any, on the purchase and sale. The optionee's  additional  gain,
or any loss, upon the disqualifying  disposition will be a capital gain or loss,
which will be long-term or short-term  depending on how long the stock was held.
Long-term  capital gains currently are generally subject to lower tax rates than
ordinary income.  The current maximum  long-term  capital gains rate for federal
income tax  purposes  is  generally  28% for assets  held for  between 12 and 18
months and 20% for assets  held for more than 18 months.  The  maximum  ordinary
income rate is effectively 39.6% at the present time.  Slightly  different rules
may apply to optionees who acquire stock subject to certain  repurchase  options
or who are subject to Section 16(b) of the Exchange Act.

     To the  extent  the  optionee  recognizes  ordinary  income  by reason of a
disqualifying  disposition,  the Company will generally be entitled  (subject to
the requirement of reasonableness,  the provisions of Section 162(m) of the Code
and the satisfaction of a tax reporting obligation) to a corresponding  business
expense deduction in the tax year in which the disqualifying disposition occurs.

     Nonstatutory  Stock Options.  Nonstatutory  stock options granted under the
Plan generally have the following federal income tax consequences:

     There are no tax  consequences  to the optionee or the Company by reason of
the grant of a nonstatutory stock option.  Upon exercise of a nonstatutory stock
option,  the optionee  normally will recognize  taxable ordinary income equal to
the excess of the  stock's  fair market  value on the date of exercise  over the
option  exercise  price.  Generally,  with respect to employees,  the Company is
required to withhold from regular wages or supplemental  wage payments an amount
based  on  the  ordinary  income  recognized.  Subject  to  the  requirement  of
reasonableness,   the   provisions  of  Section  162(m)  of  the  Code  and  the
satisfaction  of a tax  reporting  obligation,  the Company  will  generally  be
entitled to a business  expense  deduction equal to the taxable  ordinary income
realized by the  optionee.  Upon  disposition  of the stock,  the optionee  will
recognize  a capital  gain or loss equal to the  difference  between the selling
price and the sum of the amount  paid for such stock plus any amount  recognized
as ordinary  income upon exercise of the option.  Such gain or loss will be long
or short-term depending on how long the stock was held. Slightly different rules
may apply to optionees who acquire stock subject to certain  repurchase  options
or who are subject to Section 16(b) of the Exchange Act.

     Potential  Limitation  on Company  Deductions.  Section  162(m) of the Code
denies a deduction to any publicly held  corporation  for  compensation  paid to
certain  employees  in a taxable  year to the extent that  compensation  exceeds
$1,000,000 for a covered employee. It is possible that compensation attributable
to stock options, when combined with all other types of compensation received by
a covered employee from the Company, may cause this limitation to be exceeded in
any particular year.

     Certain  kinds  of  compensation,  including  qualified  "performance-based
compensation,"  are  disregarded  for purposes of the deduction  limitation.  In
accordance with Treasury  regulations issued under Section 162(m),  compensation
attributable  to stock options will qualify as  performance-based  compensation,
provided that the option is granted by a compensation committee comprised solely
of "outside  directors" and either:  (i) the option plan contains a per-employee
limitation  on the number of shares for which  options  may be granted  during a
specified  period,  the per-employee  limitation is approved by the stockholders
and the  exercise  price of the option is no less than the fair market  value of
the stock on the date of grant;  or (ii) the option is granted (or  exercisable)
only  upon  the  achievement  (as  certified  in  writing  by  the  compensation
committee) of an objective performance goal established in


                                       7.
<PAGE>


writing  by the  compensation  committee  while  the  outcome  is  substantially
uncertain, and the option is approved by stockholders.

        THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2.


                                   PROPOSAL 3

    APPROVAL OF AMENDMENT TO 1988 DIRECTORS' STOCK OPTION PLAN TO EXTEND TERM
                      AND CERTAIN ADMINISTRATIVE AMENDMENTS

     In July 1997, the Board approved an amendment to the 1988 Directors'  Stock
Option Plan (the "Directors'  Plan") to extend the term of such plan to July 27,
2007. The Board also approved certain  administrative  amendments that it deemed
advisable  as a result of  changes in the  securities  laws.  At June 30,  1997,
72,000 shares (plus any shares that might be returned to the Directors'  Plan as
a result of  cancellations  or  expiration  of options)  remained  available for
future grant under the  Directors'  Plan.  During the fiscal year ended June 30,
1997, the Company automatically granted to all non-employee directors as a group
options to purchase 6,000 shares at an exercise price of $39.50 per share.

     Stockholders  are requested in Proposal 3 to approve the  amendments to the
Directors' Plan. If the stockholders  fail to approve Proposal 3, the Directors'
Plan will  expire in 1998.  The  affirmative  vote of a  majority  of the shares
present in person or  represented  by proxy and  entitled to vote at the meeting
will be required to approve the amendments to the Directors'  Plan.  Abstentions
will be counted  towards the tabulation of votes cast on proposals  presented to
the  stockholders  and will have the same effect as negative votes.  Broker non-
votes are  counted  towards a quorum,  but are not  counted  for any  purpose in
determining whether this matter has been approved.

     The essential  features of the  Directors'  Plan, as amended,  are outlined
below:

General

     The Directors' Plan provides for the automatic grant of nonstatutory  stock
options to  directors  of the Company  who are not  otherwise  employees  of the
Company or any parent or subsidiary of the Company ("Non- Employee  Directors").
See "Federal Income Tax  Information" for a discussion of the federal income tax
treatment of nonstatutory stock options.

Purpose

     The  Directors'  Plan was adopted to provide a means by which  Non-Employee
Directors  could be given an opportunity to purchase stock in the Company and to
assist in  attracting  and  retaining  the  services of  qualified  Non-Employee
Directors. As of June 30, 1997, 78,000 options to purchase Common Stock had been
granted under the Directors' Plan.


                                       8.
<PAGE>


Administration

     The Directors'  Plan is  administered  by the Board.  The  Directors'  Plan
provides  for the  automatic  grant of an option to  purchase  10,000  shares of
Common Stock upon each Non-Employee  Director's initial election to the Board by
the Board or the  stockholders  of the Company,  and an option to purchase 2,000
shares of Common Stock each year upon such Non-Employee  Director's  re-election
to the  Board.  The  Board  is  authorized  to  delegate  administration  of the
Directors'  Plan to a  committee  composed  of not fewer than two members of the
Board.  The Board has delegated  administration  of the  Directors'  Plan to the
Compensation  Committee  of the  Board.  As  used  herein  with  respect  to the
Directors' Plan, the "Board" refers to the Compensation  Committee as well as to
the Board itself.

     Pursuant  to the  Directors'  Plan,  directors  who serve as members of the
Compensation  Committee must be "outside  directors."  This limitation  excludes
from the  Compensation  Committee  (i) current  employees of the  Company,  (ii)
former employees of the Company receiving  compensation for past services (other
than benefits  under a  tax-qualified  pension  plan),  (iii) current and former
officers  of the  Company,  and (iv)  directors  currently  receiving  direct or
indirect  remuneration  from  the  Company  in any  capacity  (other  than  as a
director),  unless any such person is otherwise considered an "outside director"
for purposes of Section 162(m).

Eligibility

     Only Non-Employee Directors are eligible to receive option grants under the
Directors' Plan. Messrs.  Anderson and Moore and Dr. Battey currently qualify as
Non-Employee  Directors and, as such,  each received an option to purchase 2,000
shares of Common  Stock in  October  1996 with an  exercise  price of $39.50 per
share.

Stock Subject to the Directors' Plan

     If options granted under the Directors' Plan expire or otherwise  terminate
without being exercised, the Common Stock not purchased pursuant to such options
again becomes available for issuance under the Directors' Plan.

Terms of Options

     The following is a description of the terms of options under the Directors'
Plan.

     Exercise  Price;  Payment.  The exercise price of options granted under the
Directors'  Plan may not be less than the fair market  value of the Common Stock
subject to the option on the date of the option  grant.  The  exercise  price of
options  granted under the Directors'  Plan must be paid either:  (a) in cash at
the time the option is  exercised;  (b) by delivery of other Common Stock of the
Company;  or (c) by some  combination  of  consideration  listed  in (a) and (b)
above.

     Option  Exercise.  Options  granted under the  Directors'  Plan vest in 25%
increments each year beginning one year from the date of grant.

     Term. The maximum term of options under the Directors'  Plan is five years.
Options under the  Directors'  Plan  terminate 30 days after  termination of the
optionee's service as a Non-Employee  Director or employee of the Company or any
affiliate of the Company,  unless such termination is due to such person's death
or permanent and total  disability  (as defined in the Code),  in which case the
option may be  exercised  at any time within one year of such  termination.  The
option term may also be extended in the event that exercise of the option within
these periods is prohibited for specified reasons.


                                       9.
<PAGE>


Adjustment Provisions

     If there is any  change  in the stock  subject  to the  Directors'  Plan or
subject  to any  option  granted  under the  Directors'  Plan  (through  merger,
consolidation,  reorganization,  recapitalization,  stock dividend,  dividend in
property  other than cash,  stock split,  liquidating  dividend,  combination of
shares,  exchange of shares,  change in corporate  structure or otherwise),  the
Directors'  Plan  and  options  outstanding  thereunder  will  be  appropriately
adjusted as to the class and the maximum  number of shares  subject to such plan
and the  class,  number of shares  and price per share of stock  subject to such
outstanding options.

Effect of Certain Corporate Events

     The  Directors'  Plan  provides  that,  in the  event of a  dissolution  or
liquidation  of the  Company,  specified  type  of  merger  or  other  corporate
reorganization,  to the extent permitted by law, any surviving  corporation will
be required to either assume options  outstanding  under the Directors'  Plan or
substitute  similar  options  for those  outstanding  under such  plan,  or such
outstanding  options will  continue in full force and effect.  In the event that
any surviving  corporation  declines to assume or continue  options  outstanding
under the  Directors'  Plan, or to  substitute  similar  options,  then the time
during which such options may be exercised will be  accelerated  and the options
terminated if not exercised  during such time. The  acceleration of an option in
the  event of an  acquisition  or  similar  corporate  event may be viewed as an
antitakeover provision,  which may have the effect of discouraging a proposal to
acquire or otherwise obtain control of the Company.

Duration, Amendment and Termination

     The Board may suspend or terminate the Directors' Plan without  stockholder
approval or  ratification  at any time or from time to time.  Excluding any such
action by the Board,  the  Directors'  Plan will terminate on July 27, 2007. The
Board  may also  amend  the  Directors'  Plan at any time or from  time to time.
However,  no amendment will be effective  unless approved by the stockholders of
the  Company if such  modification  requires  stockholder  approval  in order to
comply with Rule 16b-3 under the  Exchange  Act.  The Board may submit any other
amendment to the Directors' Plan for stockholder approval.

Restrictions on Transfer

     Under the Directors' Plan, an option may not be transferred  except by will
or by the laws of  descent  and  distribution.  In any case,  the  optionee  may
designate  in writing a third party who may  exercise the option in the event of
the optionee's death.

Federal Income Tax Information

     Nonstatutory stock options granted under the Directors' Plan generally have
the following federal income tax consequences:

     There are no tax  consequences  to the optionee or the Company by reason of
the grant of a nonstatutory stock option.  Upon exercise of a nonstatutory stock
option,  the optionee  normally will recognize  taxable ordinary income equal to
the excess of the  stock's  fair market  value on the date of exercise  over the
option  exercise  price.  Subject  to the  requirement  of  reasonableness,  the
provisions of Section 162(m) of the Code and the satisfaction of a tax reporting
obligation,  the  Company  will  generally  be  entitled  to a business  expense
deduction equal to the taxable  ordinary  income realized by the optionee.  Upon
disposition  of the stock,  the optionee  will  recognize a capital gain or loss
equal to the difference between the selling price and the sum of the amount paid
for such stock plus any amount  recognized  as ordinary  income upon exercise of
the option.  Such gain or loss will be long or short-term  depending on how long
the stock was held for more than one year.


                                      10.
<PAGE>

        THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 3.

                                   PROPOSAL 4

                        APPROVAL OF INDEPENDENT AUDITORS

     Deloitte & Touche LLP  ("Deloitte  & Touche")  has served as the  Company's
independent  auditors with respect to the Company's books and accounts since the
Company began operations in 1980.

     The  stockholders  are being  asked to ratify the  approval  of  Deloitte &
Touche as  independent  auditors  for the  fiscal  year  ending  June 30,  1998.
Although it is not  required to do so, the Board is  submitting  the approval of
Deloitte  & Touche  to the  stockholders  for  ratification  as a matter of good
corporate  practice.  Should the stockholders fail to provide such ratification,
the Board would  reconsider  its  approval  of Deloitte & Touche as  independent
auditors  for the fiscal year ending June 30,  1998.  Even if the  selection  is
ratified,  the Board in its discretion may direct the appointment of a different
independent  auditing  firm at any time during the year if the Board  determines
that  such a change  would  be in the  best  interests  of the  Company  and its
stockholders.

     Representatives  of  Deloitte  & Touche are  expected  to be present at the
Annual Meeting of  Stockholders.  They do not expect to make any statement,  but
will have the  opportunity  to make a statement if they desire to do so and will
be available to respond to appropriate questions.

     The  affirmative  vote of the  holders  of a majority  of the Common  Stock
present in person or  represented  by proxy and entitled to vote on the proposal
at the Annual  Meeting  will be required to ratify the  selection  of Deloitte &
Touche.

                 THE BOARD OF DIRECTORS RECOMMENDS RATIFICATION
                     OF THE SELECTION OF DELOITTE & TOUCHE.


                                      11.
<PAGE>


         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The following table sets forth certain information  regarding the ownership
of the Company's  Common Stock as of August 1, 1997 by (i) each  director,  (ii)
each Named Executive Officer (as defined under "Executive Compensation"),  (iii)
all executive  officers and directors as a group and (iv) all those known by the
Company to be beneficial owners of more than five percent of its Common Stock:

                                                         Beneficial Ownership(1)
                                                         -----------------------
                                                         Number        Percent
Name of Beneficial Owner                                of Shares     of Class
- ------------------------                                ---------     --------
Pioneering Management Corporation(2) ................   1,388,000      11.9%
  60 State Street
  Boston, MA 02109
Janus Capital Corporation(3) ........................     930,015       8.0%
  100 Fillmore Street #300
  Denver, CO 80206
A. Blaine Bowman(4)(5) ..............................     736,976       6.1%
James F. Battey .....................................     267,690       2.3%
Barton Evans, Jr.(5) ................................     176,115       1.5%
David L. Anderson(5)(6) .............................     154,060       1.3%
Nebojsa Avdalovic(5) ................................      42,084       *
Michael Pope(5) .....................................      29,160       *
B. J. Moore(5) ......................................      18,020       *
Bruce Barton(5) .....................................      16,668       *
All executive officers and directors as a group
  (10 persons)(7) ...................................   1,486,854      12.1%

- ----------

* Less than one percent.

     1This table is based upon information  supplied by officers,  directors and
     principal  stockholders and Schedules 13D and 13G filed with the Securities
     and Exchange  Commission  (the "SEC").  Unless  otherwise  indicated in the
     footnotes  to this table,  and  subject to  community  property  laws where
     applicable,  each of the  stockholders  named in this table has sole voting
     and investment  power with respect to the shares  indicated as beneficially
     owned. Applicable percentages are based on 11,677,661 shares outstanding on
     August 1, 1997 adjusted as required by rules promulgated by the SEC.

     2Pioneering  Management  Corporation is a registered investment adviser. Of
     the shares set forth  above,  as of August 1, 1997,  Pioneering  Management
     Corporation had shared  investment power with respect to 1,188,000  shares,
     sole investment  power with respect to 200,000 shares and sole voting power
     with respect to 1,388,000 shares.

     3Janus Capital Corporation ("Janus") is a registered investment advisor. As
     of August 1, 1997,  Janus had  shared  dispositive  and  voting  power with
     respect to all of the shares set forth above.

     4Includes  26,132  shares  held of record by a trust for the benefit of Mr.
     Bowman's minor daughter, as to which shares Mr. Bowman disclaims beneficial
     ownership.


                                      12.
<PAGE>



     5Includes shares subject to outstanding stock options that were exercisable
     on  August  1,  1997  or  that  could  become  exercisable  within  60 days
     thereafter,  as follows:  Mr. Bowman,  382,200 shares;  Mr. Evans,  135,000
     shares;  Mr. Anderson,  3,000 shares;  Mr.  Avdalovic,  41,000 shares;  Mr.
     Barton,  14,750  shares;  Mr. Pope,  26,000  shares;  and Mr. Moore,  3,000
     shares.

     6Includes  10,650  shares held by Mr.  Anderson as custodian  for his minor
     son, as to which shares Mr. Anderson disclaims beneficial ownership.

     7Includes shares  described in the notes above, as applicable,  and 649,977
     shares  subject  to  outstanding  stock  options  held by  other  executive
     officers of the Company  that were  exercisable  on August 1, 1997 or could
     become exercisable within 60 days thereafter.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

     Section  16(a) of the Exchange Act requires  the  Company's  directors  and
executive  officers,  and persons who own more than ten percent of a  registered
class of the Company's equity  securities,  to file with the SEC initial reports
of  ownership  and  reports of changes in  ownership  of Common  Stock and other
equity securities of the Company. Executive officers, directors and greater than
ten percent  stockholders  are required by SEC regulation to furnish the Company
with copies of all Section 16(a) forms they file.

     To the Company's knowledge,  based solely on a review of the copies of such
reports  furnished  to the  Company and  written  representations  that no other
reports were required, during the fiscal year ended June 30, 1997, the Company's
executive  officers and directors  complied with applicable Section 16(a) filing
requirements.

                             EXECUTIVE COMPENSATION

Compensation of Directors

     Each Non-Employee Director received an annual fee of $15,000 in fiscal 1997
and $1,000 for each regularly  scheduled meeting  attended,  including the Audit
Committee meeting,  and $750 for every other meeting attended.  The fees payable
to Non-Employee  Directors  during fiscal 1998 will remain the same as in fiscal
1997.  In addition,  each  Non-Employee  Director is eligible for option  grants
under the  Directors'  Plan.  Options to purchase  8,000  shares of Common Stock
granted under the  Directors'  Plan were  exercised  during fiscal 1997, and the
value realized upon exercise of such options was $209,188.


                                      13.
<PAGE>


Compensation of Executive Officers

     The following  table sets forth,  for the fiscal years ended June 30, 1997,
1996,  and 1995,  certain  compensation  awarded  or paid to, or earned  by, the
Company's  Chief  Executive  Officer  and the  Company's  four other most highly
compensated   executive   officers  at  June  30,  1997  (the  "Named  Executive
Officers").

<TABLE>
<CAPTION>
                                             SUMMARY COMPENSATION TABLE

Name and Principal Position             Year               Annual Compensation                 Long-Term            All Other
- ---------------------------             ----               -------------------               Compensation         Compensation   
                                                                                                Awards                 (3)       
                                                                                                ------                 ---       
                                                                                                                                 
                                                                                              Securities                         
                                                                                              Underlying                         
                                                                                                Options                          
                                                                                                -------                          
                                                         Salary(1)            Bonus(2)
                                                         ---------            --------

<S>                                   <C>                 <C>               <C>                   <C>                  <C>   
A. Blaine Bowman ..................   1997                $319,904          $345,413(4)           100,000              $8,000
  President and                       1996                 303,465           320,859(4)                --               7,408
  Chief Executive Officer             1995                 286,212           278,710               70,000               7,841

Barton Evans, Jr. .................   1997                $192,946             $120,077            28,000              $8,011
  Senior Vice President               1996                 183,273               97,299                --               7,474
                                      1995                 173,099               79,784            30,000               7,471

Nebojsa Avdalovic .................   1997                $163,008              $55,004             9,000              $7,113
  Vice President                      1996                 155,515               69,026                --               7,856
                                      1995                 150,012               59,622            14,000               7,782

Bruce Barton(5) ...................   1997                $125,954              $81,974            18,000              $8,080
  Vice President

Michael Pope ......................   1997                $146,031              $66,433            18,000              $8,134
  Vice President and                  1996                 137,254               56,537                --               8,333
  Chief Financial Officer             1995                 105,924               50,762            22,000               7,096
</TABLE>




(1)  Includes amounts earned but deferred at the election of the Named Executive
     Officers pursuant to the Company's 401(k) Plan.

(2)  Amounts shown include  amounts earned under the Company's  Employee  Profit
     Sharing  Plan and the  Management  Bonus Plan.  Under the  Employee  Profit
     Sharing  Plan,  amounts  earned  in  fiscal  years  1997,  1996,  and 1995,
     respectively, were as follows: Mr. Bowman $70,413, $70,859 and $54,710; Mr.
     Evans $33,077,  $31,299 and $23,784;  Dr.  Avdalovic  $23,004,  $25,026 and
     $19,622;  and Mr. Pope $22,433,  $21,537 and $14,762.  Under the Management
     Bonus  Plan,   amounts  earned  in  fiscal  years  1997,   1996  and  1995,
     respectively,  were as follows: Mr. Bowman $275,000, $250,000 and $224,000;
     Mr. Evans $87,000,  $66,000 and $56,000; Dr. Avdalovic $32,000, $44,000 and
     $40,000;  and Mr. Pope $44,000,  $35,000 and $36,000.  In fiscal 1997,  Mr.
     Barton earned  $21,974 under the Employee  Profit  Sharing Plan and $60,000
     under the Management Bonus Plan.

(3)  Amounts shown include Company contributions to the Company's 401(k) Plan.

(4)  Includes  $175,000 and $150,000  deferred at the election of Mr. Bowman for
     fiscal  1997 and  fiscal  1996,  respectively,  pursuant  to the  Company's
     compensation deferral plan established by the Company for Mr. Bowman.




                                      14.
<PAGE>


(5)  Mr.  Barton  became an  executive  officer  of the  Company  in July  1996.
     Therefore, no amounts are shown for fiscal 1996 and 1995.

Stock Option Grants and Exercises

     The Company  grants  options to its executive  officers under the Plan. The
Plan will  terminate in July 2005 unless sooner  terminated by the Board.  As of
June 30, 1997,  options to purchase a total of 1,504,088 shares had been granted
and  were  outstanding  under  the  Plan  and  the  Company's  now-expired  1984
Supplemental  Stock Option Plan.  Options to purchase  711,677  shares  remained
available for grant under the Plan.

     The following tables show, for the fiscal year ended June 30, 1997, certain
information  regarding  options granted to, exercised by and held at year end by
the Named Executive Officers.

                        OPTION GRANTS IN LAST FISCAL YEAR


                                      15.
<PAGE>

<TABLE>
<CAPTION>
                                        Individual Grants
                                        -----------------
Name                                    Number of     % of Total      Exercise       Expiration         Potential Realizable Value
- ----                                   Securities      Options         or Base          Date             at Assumed Annual Rates  
                                       Underlying     Granted to        Price           ----           of Stock Price Appreciation
                                         Options      Employees          Per                               for Option Term(3)       
                                        Granted(1)     in Fiscal         Share                             ------------------       
                                        ----------      Year(2)          -----                              5%              10%   
                                                        -------                                             --              ---   
<S>                                     <C>             <C>           <C>             <C>              <C>                <C>       
Mr. Bowman .................            100,000         27.9%         $32.625         12/17/06         $2,051,769         $5,199,585
Mr. Evans ..................             28,000          7.8%         $32.625         12/17/06           $574,495         $1,455,884
Dr. Avdalovic ..............              9,000          2.5%         $32.625         12/17/06           $184,659           $467,963
Mr. Pope ...................             18,000          5.0%         $32.625         12/17/06           $369,318           $935,925
Mr. Barton .................             18,000          5.0%         $32.625         12/17/06           $369,318           $935,925
- ------------------------------------------------------------------------------------------------------------------------------------
All stockholders as a group(4)                                                                             $244.7             $620.2
                                                                                                          million            million
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

(1)  Consists of nonstatutory stock options to purchase 173,000 shares of Common
     Stock  granted  under the Plan.  Each of such options has a ten-year  term,
     subject to earlier  termination  upon death,  disability or  termination of
     employment,  and vest in four equal annual installments  beginning one year
     from the date of the grant.  The exercise  prices of such options are equal
     to 100% of the fair market value of the Company's  Common Stock at December
     18, 1996 based on the closing  sales price of the Common  Stock as reported
     on the Nasdaq  National  Market for the  business  day prior to the date of
     grant.  Options granted under the Plan generally  expire ten years from the
     date of the  grant  and  become  exercisable  in 25%  increments  each year
     beginning one year from the date of the grant. The Plan contains provisions
     permitting  the Board to  accelerate  vesting of  outstanding  options.  In
     addition,  in the event of a dissolution or  liquidation of the Company,  a
     specified stockholder-approved merger or a sale of all or substantially all
     of the assets of the Company,  to the extent permitted by law, vesting with
     respect to each  outstanding  option  will  automatically  be  accelerated,
     unless such options are either assumed by any successor corporation (or its
     parent  corporation) or are otherwise  replaced with comparable  options to
     purchase  shares of the  capital  stock of such  successor  corporation  or
     parent thereof. See Proposal 2 above for further information  regarding the
     terms of options granted under the Plan.

(2)  Based on 358,200 options granted to employees in fiscal 1997.

(3)  In  accordance  with  the  rules of the  SEC,  the  table  sets  forth  the
     hypothetical gains or "option spreads" that would exist for such options at
     the end of their respective  terms.  These gains are based on assumed rates
     of annual compound stock price  appreciation of 5% and 10% from the date of
     grant to the end of the option term (ten years).  The potential  realizable
     value is  calculated  by assuming that the stock price on the date of grant
     appreciates  at the  indicated  annual  rate,  compounded  annually for the
     entire term of the option, and that the option is exercised and sold on the
     last  day of its  term at the  appreciated  stock  price.  For  example,  a
     stockholder  who  purchased  one  share of stock on  December  18,  1996 at
     $32.625, held the stock for ten years (while the stock appreciated at 5% or
     10% annual rate, respectively) and sold it on December 17, 2006, would have
     profits  of  $20.52  and  $52.00,  respectively,  on  his  or  her  $32.625
     investment.  No gain to the  optionee is  possible  unless the price of the
     Company's  stock  increases  over the option  term,  benefiting  all of the
     Company's  stockholders.  These amounts  represent certain assumed rates of
     appreciation in accordance with the rules of the SEC and do not reflect the
     Company's estimate or projection of future stock price performance.  Actual
     gains,  if any,  are  dependent  on the actual  future  performance  of the
     Company's Common Stock.

(4)  These amounts  represent the increase in the aggregate  market value of the
     Common  Stock  outstanding 



                                      16.
<PAGE>

     as of December 18, 1996  (11,926,994  shares)  assuming the annual rates of
     stock price  appreciation set forth above over the ten-year period used for
     the Named Executive Officers.

<TABLE>
<CAPTION>
                                AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND
                                           FISCAL YEAR-END OPTION VALUES

Name                                     Number of          Value           Number of Securities       Value of Unexercised In-the-
- ----                                      Shares         Realized(1)             Underlying                        Money            
                                        Acquired On      -----------   Unexercised Options at Fiscal    Options at Fiscal Year End  
                                         Exercise                                 Year End                                          
                                         --------                       Exercisable/Unexercisable(2)   Exercisable/Unexercisable(3) 
                                                                        ----------------------------   ---------------------------- 
<S>                                       <C>             <C>                 <C>       <C>              <C>          <C>       
Mr. Bowman .....................          88,000          $3,320,313          365,200 / 152,000          $14,282,750 /$3,518,500
Mr. Evans ......................            --                --               126,500 / 51,500          $4,872,438 /$1,273,562
Dr. Avdalovic ..................            --                --                36,750 / 20,250           $1,309,406 /$528,469
Mr. Pope .......................            --                --                22,250 / 32,750            $742,719 /$819,531
Mr. Barton .....................            --                --                11,750 / 28,500            $380,250 /$667,688
</TABLE>


(1)  Represents  the fair market value of the  underlying  shares on the date of
     exercise  (based  upon the  closing  sales  price  reported  on The  Nasdaq
     National  Market or the actual  sales  price if the shares were sold by the
     optionee) less the exercise price.

(2)  Includes both in-the-money and out-of-the-money options.

(3)  Represents the fair market value of the  underlying  shares on the last day
     of the fiscal year ($51.25  based on the closing  sales price of the Common
     Stock as reported on The Nasdaq National Market) less the exercise price.



                                      17.
<PAGE>


                         COMPENSATION COMMITTEE REPORT1

     The  Compensation  Committee  of the Board (the  "Committee")  consists  of
non-employee directors and establishes compensation policy and practices for the
Company's Chief Executive Officer ("CEO") and its other executive officers.  All
compensation  at the Company is based upon a sustained  high level of individual
performance  and the  Company's  overall  performance.  The  Committee  provides
direction and makes  recommendations  on all  compensation  matters  relating to
executive officers and other senior management employees, including stock option
grants.

Compensation Philosophy

     The  goal  of  the  compensation  program  is to  tie  compensation  to the
attainment  of specific  business and  individual  objectives,  while  providing
compensation  sufficient  to  attract,  retain,  motivate  and reward  executive
officers and other key employees who contribute to the long-term  success of the
Company.  In furtherance of these goals,  annual base salaries are generally set
at levels that take into account both competitive and performance  factors.  The
Company also relies to a significant degree on annual and longer-range incentive
compensation  in  order  to  attract  and  motivate  its  executives.  Incentive
compensation  is  variable  and is  closely  tied to  corporate  performance  to
encourage  profitability  growth and the enhancement of stockholder  value.  The
Company's total compensation package,  composed of base salary, bonus awards and
stock option  grants,  is designed to be  competitive  with leading  separations
science  and high  technology  companies  with which the  Company  competes  for
people.

Cash-Based Compensation

     Cash-based compensation paid to executive officers in fiscal 1997 consisted
of base salary,  including amounts received  pursuant to the Company's  Employee
Profit  Sharing  Plan,  and  an  annual  incentive  award  under  the  Company's
Management  Bonus Plan. For fiscal 1997, in making its  competitive  analysis of
cash-based  executive  compensation,  the Committee reviewed surveys provided by
Towers  Perrin,  Hewitt and  Associates and the Western  Management  Group,  all
nationally  recognized  consulting   organizations   specializing  in  executive
compensation,  of compensation paid to executive officers of separations science
and high technology companies.  Generally, the Committee sets annual base salary
levels and bonus amounts to provide for a total cash-based  compensation that is
within the second and third quartiles of compensation paid to executive officers
of  separations  science and high  technology  companies  with which the Company
competes for talented executives.

     Base Salary

     The Committee  annually  reviews and adjusts each executive  officer's base
salary.  To ensure retention of qualified  management,  the Committee  generally
targets base salaries paid to executive officers at competitive levels, based on
the surveys  described  above.  In addition,  when reviewing base salaries,  the
Committee  considers  both  qualitative  and  quantitative  factors  relating to
individual and corporate performance, levels of responsibility, prior experience
and breadth of knowledge.  The Committee does not base its considerations on any
single one of these factors nor does it specifically  assign relative weights to
factors.  In many  instances,  the  qualitative  factors  necessarily  involve a
subjective  assessment  by  the  Committee.  Generally,  in  determining  salary
adjustments for executive officers (other than the chief executive officer), the
Committee relies primarily on the evaluation and recommendations of Mr. Bowman.

- ----------

1 The  material  in this  report is not  "soliciting  material,"  is not  deemed
"filed" with the SEC and is not to be incorporated by reference in any filing of
the  Company  under the  Securities  Act of 1933 (the  "Securities  Act") or the
Exchange Act,  whether made before or after the date hereof and  irrespective of
any general incorporation language in any such filing.



                                      18.
<PAGE>


     Employee Profit Sharing Plan

     The  Company's   Employee   Profit  Sharing  Plan  (the  "EPSP")  has  been
established  to reward all North  American  full-time  employees of the Company,
including  executive   officers,   for  their  contributions  to  the  Company's
profitability  for any given year.  The  structure of the EPSP  provides for the
development of a compensation  pool, the size of which is based on profits for a
given year.  In fiscal  1997,  each  eligible  employee,  including  each of the
executive   officers,   received  pursuant  to  the  EPSP  an  amount  equal  to
approximately 11.8% of such employee's eligible compensation.

     Annual Incentive Award

     The Management  Bonus Plan (the "MBP"),  an annual incentive award plan, is
the variable pay program for officers and other senior  managers of the Company.
The  actual  bonus  award  earned  depends on the  extent to which  Company  and
individual  performance  objectives  are  achieved  for any given year.  Company
objectives  consist of achieving  operating,  strategic and financial goals that
are  considered to be critical to the Company's  fundamental  long-term  goal of
building  stockholder value. The Company does not set any specific target levels
of compensation nor does it base its bonus  determinations on achievement of all
criteria.  At the end of each fiscal year, the Committee evaluates the degree to
which the Company has met its goals in light of its historical and industry-wide
performance.  The Committee then determines  individual  awards under the MBP by
evaluating each  participant's  contribution to the achievement of the Company's
objectives  and overall  individual  performance as well as by ensuring that the
bonus awards remain at competitive levels.

     Cash-based Compensation For Fiscal 1997

     The amount of the aggregate of Mr.  Bowman's base salary and EPSP award for
fiscal  1996,  in addition to his annual  bonus under the MBP,  was in the third
quartile compared to the surveyed group of leading  separations science and high
technology  companies.  Following a review of the above-described  surveys,  the
Committee  set Mr.  Bowman's  base annual  salary for fiscal  1997 at  $320,000,
representing an increase of 5% over his base salary for fiscal 1996.

     In setting Mr.  Bowman's base salary and amount of award under the MBP, the
Committee  took into  account,  in addition to  competitive  consideration,  the
Committee's  evaluation of Mr.  Bowman's  contribution to the performance of the
Company in fiscal 1997. In particular, the Committee took into consideration the
Company's financial  performance,  including sales growth and profitability,  as
well as  contributions  by Mr. Bowman to achievements in strategic  planning and
positioning.   The  Committee  also  considered  Mr.  Bowman's   leadership  and
experience in the  separations  science  industry and the scope of Mr.  Bowman's
responsibility  and rated Mr.  Bowman's  individual  performance as exceptional.
This performance level resulted in an annual bonus award to him of $275,000.

     Similar competitive  consideration and corporate and individual performance
factors   accounted   for  increases  in  base  salaries  and  were  taken  into
consideration in determining  awards under the MBP for other executive  officers
for fiscal 1997. The percentage  increase in base salaries of executive officers
ranged  from 4% to 5%. The  executive  officers  received  awards  under the MBP
ranging from 20% to 48% of their base salaries.

     Long-Term Incentives

     The Company utilizes a long-term incentive program, currently consisting of
the Dionex  Corporation  Stock Option Plan (the "Plan") and,  until August 1994,
also  consisting  of the  Supplemental  Stock Option Plan,  to further align the
interests of stockholders and management by creating common  incentives  related
to the  possession  by  management  of a  substantial  economic  interest in the
long-term  appreciation  of the Company's  stock.  In determining the size of an
option to be granted to an executive  officer,  the Committee takes into account
the  officer's  position and level of  responsibility  within the  Company,  the
officer's existing stock and unvested option holdings, the potential


                                      19.
<PAGE>


reward to the officer if the stock price  appreciates in the public market,  and
the  competitiveness  of  the  officer's  overall   compensation   arrangements,
including stock options.  Additional  long-term  incentives are provided through
the Company's Employee Stock Participation Plan in which all eligible employees,
including eligible executive officers of the Company,  may purchase stock of the
Company, subject to specified limits, at 85% of fair market value.

     In fiscal 1997, Mr. Bowman was granted an option to purchase 100,000 shares
and the other  executive  officers  were granted  options to purchase  shares in
amounts  ranging  from  9,000 to 28,000  shares.  No  options  were  granted  to
executive officers in fiscal 1996.

     Section  162(m) of the Code limits the Company to a deduction,  for federal
income tax purposes,  of no more than $1 million of compensation paid to certain
named executive officers in a taxable year. Compensation above $1 million may be
deducted if it is "performance-based  compensation." The Compensation  Committee
has determined  that stock options granted under the Plan with an exercise price
at least equal to the fair market  value of the  Company's  common  stock on the
date of grant shall be treated as  "performance-based  compensation."  In fiscal
1996, the Company's  stockholders approved an amendment to the Plan that enables
any  compensation  recognized  by a Named  Executive  Officer as a result of the
grant of such a stock option that qualifies as "performance-based  compensation"
and thus be  deductible  by the Company  without  regard to the $1 million limit
otherwise imposed by Code Secton 162(m). The Committee believes that it is quite
unlikely that  compensation,  excluding  the value of any stock options  granted
under the Plan paid to any Named  Executive  Officer in a taxable  year which is
subject to the limitation will exceed $1 million.


                                                          DAVID L. ANDERSON
                                                     JAMES F. BATTEY
                                                     B. J. MOORE


                                      20.
<PAGE>




                       PERFORMANCE MEASUREMENT COMPARISON1

     The  following  chart shows  total  stockholder  return for the  Standard &
Poor's 500 Stock Index,  a peer group index  comprised  of all public  companies
using SIC Code 3826 (Laboratory Analytical  Instruments) (the "Peer Group")2 and
for the Company:

<TABLE>
<CAPTION>
           Comparison of 5-Year Total Cumulative Return on Investment4

- --------------------------------------FISCAL YEAR ENDING----------------------------------------
COMPANY             1992      1993           1994           1995           1996           1997
<S>                 <C>       <C>            <C>            <C>            <C>            <C>   
DIONEX CORP         100       129.09         120.91         166.36         234.55         372.73
PEER GROUP          100       106.18         111.44         138.79         189.88         232.22
S + P 500           100       113.65         115.25         145.30         183.09         246.61
</TABLE>

- --------

1    This Section is not  "soliciting  material," is not deemed "filed" with the
     SEC and is not to be incorporated by reference in any filing of the Company
     under the Securities Act or the Exchange Act,  whether made before or after
     the date hereof and irrespective of any general  incorporation  language in
     any such filing.

2    Upon written  request of a stockholder,  the Company will provide a list of
     companies  comprising  the Peer Group as well as the list of companies that
     were  included in the prior  year's Peer Group but are not included in this
     year's Peer Group because such companies are no longer listed under the SIC
     Code 3826 and  companies  that were not  included in the prior  year's Peer
     Group but are included in this year's Peer Group because such companies are
     currently, but were not in the prior year, listed under the SIC Code 3826.

3    The total  return on  investment  (change  in  year-end  stock  price  plus
     reinvested dividends) for the Company, the S&P 500 Stock Index and the Peer
     Group,  based on June 30, 1992 = 100. In  accordance  with the rules of the
     SEC,  the  returns of  companies  comprising  the Peer  Group are  weighted
     according to their respective stock market  capitalization at the beginning
     of each period for which a return is indicated.



                                      21.
<PAGE>





21322890
082197


<PAGE>


                                  OTHER MATTERS

     The  Board  does not know of any other  matters  that may come  before  the
meeting.  If any other matters are properly presented to the meeting,  it is the
intention of the persons named in the  accompanying  proxy to vote, or otherwise
to act, in accordance with their best judgment on such matters.

                              STOCKHOLDER PROPOSALS

     Proposals  of  stockholders  that  are  intended  to be  presented  at  the
Company's 1998 Annual Meeting of Stockholders must be received by the Company no
later than May 15, 1998 in order to be included in the proxy statement and proxy
relating to that meeting.

                                   By Order of the Board of Directors


                                   JAMES C. GAITHER
                                   Secretary

September 12, 1997


                                      22.
<PAGE>

                               DIONEX CORPORATION

                                STOCK OPTION PLAN

                     (As Amended and Restated July 28, 1997)

1.   PURPOSES.

     (a) The  purpose  of the  Plan is to  provide  a means  by  which  selected
Employees of and Consultants to the Company, and its Affiliates, may be given an
opportunity to purchase stock of the Company.

     (b) The  Company,  by means of the Plan,  seeks to retain the  services  of
persons  who  are  now  Employees  of or  Consultants  to  the  Company  or  its
Affiliates,  to secure and retain the services of new Employees and Consultants,
and to provide  incentives  for such  persons to exert  maximum  efforts for the
success of the Company and its Affiliates.

     (c) The Company  intends that the Options  issued under the Plan shall,  in
the  discretion  of the  Board  or any  Committee  to which  responsibility  for
administration  of the Plan has been delegated  pursuant to subsection  3(c), be
either Incentive Stock Options or Nonstatutory Stock Options.  All Options shall
be separately  designated  Incentive Stock Options or Nonstatutory Stock Options
at the time of grant,  and in such form as issued  pursuant  to Section 6, and a
separate  certificate  or  certificates  will be issued for shares  purchased on
exercise of each type of Option.

2.   DEFINITIONS.

     (a)  "Affiliate"  means any parent  corporation or subsidiary  corporation,
whether now or hereafter existing, as those terms are defined in Sections 424(e)
and (f) respectively, of the Code.

     (b) "Board" means the Board of Directors of the Company.



                                       1.
<PAGE>


     (c) "Code"  means the  Internal  Revenue  Code of 1986,  as  amended. 

     (d) "Committee" means a Committee appointed by the Board in accordance with
subsection 3(c) of the Plan.

     (e) "Company" means Dionex Corporation, a Delaware corporation.

     (f)  "Consultant"  means any person,  including an advisor,  engaged by the
Company or an Affiliate to render consulting services and who is compensated for
such services,  provided that the term "Consultant"  shall not include Directors
who are paid only a director's fee by the Company or who are not  compensated by
the Company for their services as Directors.

     (g) "Continuous  Status as an Employee or Consultant"  means the employment
or relationship as a Consultant is not interrupted or terminated.  The Board, in
its sole discretion,  may determine whether  Continuous Status as an Employee or
Consultant  shall be  considered  interrupted  in the case of:  (i) any leave of
absence  approved by the Board,  including sick leave,  military  leave,  or any
other  personal  leave;  or (ii) transfers  between  locations of the Company or
between the Company, Affiliates or their successors.

     (h) "Covered  Employee" means the chief executive  officer and the four (4)
other highest compensated officers of the Company for whom total compensation is
required to be reported to  shareholders  under the Exchange  Act, as determined
for purposes of Section 162(m) of the Code.

     (i) "Director" means a member of the Board.

     (j) "Employee" means any person, including Officers and Directors, employed
by the Company or any  Affiliate of the Company.  Neither  service as a Director
nor payment of a director's fee by the Company shall be sufficient to constitute
"employment" by the Company.

     (k) "Exchange Act" means the Securities Exchange Act of 1934, as amended.


                                       2.
<PAGE>


     (l) "Fair  Market  Value"  means,  as of any date,  the value of the common
stock of the Company determined as follows:

          (1) If the common stock is listed on any established stock exchange or
     a national market system,  including without limitation the Nasdaq National
     Market,  the Fair  Market  Value of a share of  common  stock  shall be the
     closing  sales price for such stock (or the  closing  bid, if no sales were
     reported) as quoted on such system or exchange  (or the  exchange  with the
     greatest  volume of trading in common stock) on the last market trading day
     prior to the day of  determination,  as reported in the Wall Street Journal
     or such other source as the Board deems reliable;

          (2) If the common stock is not quoted on the Nasdaq  National  Market,
     or if the  common  stock is  regularly  quoted by a  recognized  securities
     dealer but selling  prices are not  reported,  the Fair  Market  Value of a
     share of common  stock shall be the mean  between the bid and asked  prices
     for the common  stock on the last  market  trading  day prior to the day of
     determination,  as reported in the Wall Street Journal or such other source
     as the Board deems reliable;

          (3) In the absence of an established  market for the common stock, the
     Fair Market Value shall be determined in good faith by the Board.

     (m)  "Incentive  Stock  Option"  means an Option  intended to qualify as an
incentive  stock  option  within the  meaning of Section 422 of the Code and the
regulations promulgated thereunder.

     (n)  "Non-Employee  Director"  means a  Director  who  either  (i) is not a
current Employee or Officer of the Company or its parent or subsidiary, does not
receive compensation  (directly or indirectly) from the Company or its parent or
subsidiary for services rendered as a


                                       3.
<PAGE>


Consultant or in any capacity other than as a Director  (except for an amount as
to which  disclosure  would not be required  under Item 404(a) of Regulation S-K
promulgated  pursuant to the Securities Act of 1933 ("Regulation S-K"), does not
possess an interest in any other  transaction  as to which  disclosure  would be
required  under Item 404(a) of Regulation  S-K, and is not engaged in a business
relationship  as to which  disclosure  would be  required  under Item  404(b) of
Regulation S-K; or (ii) is otherwise  considered a  "non-employee  director" for
purposes of Rule 16b-3.

     (o) "Nonstatutory  Stock Option" means an Option not intended to qualify as
an Incentive Stock Option.

     (p)  "Officer"  means a person who is an officer of the Company  within the
meaning  of  Section  16 of the  Exchange  Act and  the  rules  and  regulations
promulgated thereunder.

     (q) "Option" means a stock option granted pursuant to the Plan. 

     (r) "Option Agreement" means a written agreement between the Company and an
Optionee evidencing the terms and conditions of an individual Option grant. Each
Option Agreement shall be subject to the terms and conditions of the Plan.

     (s)  "Optionee"  means an Employee or Consultant  who holds an  outstanding
Option.

     (t)  "Outside  Director"  means a Director  who either (i) is not a current
employee of the Company or an  "affiliated  corporation"  (within the meaning of
the Treasury regulations promulgated under Section 162(m) of the Code), is not a
former  employee  of  the  Company  or  an  "affiliated  corporation"  receiving
compensation  for prior  services  (other than  benefits  under a tax  qualified
pension plan), was not an officer of the Company or an "affiliated  corporation"
at any time, and is not currently receiving direct or indirect remuneration from
the Company or


                                       4.
<PAGE>


an  "affiliated  corporation"  for  services  in any  capacity  other  than as a
Director,  or (ii) is otherwise considered an "outside director" for purposes of
Section 162(m) of the Code.

     (u) "Plan" means this Dionex Corporation Stock Option Plan.

     (v) "Rule 16b-3"  means Rule 16b-3 of the Exchange Act or any  successor to
Rule 16b-3,  as in effect when discretion is being exercised with respect to the
Plan.

3.   ADMINISTRATION.

     (a) The Plan shall be  administered by the Board unless and until the Board
delegates administration to a Committee, as provided in subsection 3(c).

     (b) The Board shall have the power,  subject to, and within the limitations
of, the express provisions of the Plan:

          (1) To determine from time to time which of the persons eligible under
     the Plan  shall be  granted  Options;  when  and how each  Option  shall be
     granted;  whether  an  Option  will  be  an  Incentive  Stock  Option  or a
     Nonstatutory  Stock Option;  the  provisions of each Option  granted (which
     need not be  identical),  including  the time or times  such  Option may be
     exercised in whole or in part; and the number of shares for which an Option
     shall be granted to each such person.

          (2) To construe and interpret  the Plan and Options  granted under it,
     and  to  establish,   amend  and  revoke  rules  and  regulations  for  its
     administration.  The Board, in the exercise of this power,  may correct any
     defect,  omission or inconsistency in the Plan or in any Option  Agreement,
     in a manner and to the extent it shall deem  necessary or expedient to make
     the Plan fully effective.

          (3) To amend the Plan or an Option as provided in Section 11.


                                       5.
<PAGE>


          (4) Generally, to exercise such powers and to perform such acts as the
     Board deems  necessary or  expedient  to promote the best  interests of the
     Company.

     (c) The  Board  may  delegate  administration  of the  Plan to a  committee
composed of not fewer than two (2) members (the "Committee"), all of the members
of which  Committee  may be  Non-Employee  Directors  and may  also  be,  in the
discretion of the Board, Outside Directors.  If administration is delegated to a
Committee,  the Committee shall have, in connection with the  administration  of
the Plan, the powers theretofore  possessed by the Board (and references in this
Plan to the Board shall thereafter be to the Committee),  subject,  however,  to
such  resolutions,  not inconsistent  with the provisions of the Plan, as may be
adopted from time to time by the Board.  The Board may abolish the  Committee at
any time and revest in the Board the administration of the Plan. Notwithstanding
anything  in this  Section 3 to the  contrary,  the Board or the  Committee  may
delegate to a committee  of one or more  members of the Board the  authority  to
grant Options to eligible  persons who (1) are not then subject to Section 16 of
the Exchange Act and/or (2) are either (i) not then  Covered  Employees  and are
not  expected  to be  Covered  Employees  at the time of  recognition  of income
resulting from such Option, or (ii) not persons with respect to whom the Company
wishes to comply with Section 162(m) of the Code.

4.   SHARES SUBJECT TO THE PLAN.

     (a) Subject to the  provisions of Section 10 relating to  adjustments  upon
changes in stock,  the stock  that may be sold  pursuant  to  Options  shall not
exceed in the aggregate Three Million (3,000,000) shares of the Company's common
stock.  If any Option  shall for any reason  expire or otherwise  terminate,  in
whole or in part, without having been exercised in full, the


                                       6.
<PAGE>


stock not purchased under such Option shall revert to and again become available
for issuance under the Plan.

     (b) The stock  subject  to the Plan may be  unissued  shares or  reacquired
shares, bought on the market or otherwise.

5.   ELIGIBILITY.

     (a) Incentive Stock Options may be granted only to Employees.  Nonstatutory
Stock Options may be granted only to Employees or Consultants.

     (b) No person shall be eligible for the grant of an Incentive  Stock Option
if, at the time of grant,  such  person  owns (or is deemed to own  pursuant  to
Section 424(d) of the Code) stock  possessing more than ten percent (10%) of the
total combined  voting power of all classes of stock of the Company or of any of
its Affiliates  unless the exercise price of such Option is at least one hundred
ten percent  (110%) of the Fair Market  Value of such stock at the date of grant
and the Incentive Stock Option is not  exercisable  after the expiration of five
(5) years from the date of grant.

     (c) Subject to the  provisions of Section 10 relating to  adjustments  upon
changes in stock,  no person  shall be eligible to be granted  Options  covering
more than two hundred thousand (200,000) shares of the Company's common stock in
any twelve (12)-month period.

6.   OPTION PROVISIONS.

     Each  Option  shall be in such  form  and  shall  contain  such  terms  and
conditions  as the Board  shall deem  appropriate.  The  provisions  of separate
Options  need  not  be  identical,   but  each  Option  shall  include  (through
incorporation of provisions  hereof by reference in the Option or otherwise) the
substance of each of the following provisions:


                                       7.
<PAGE>


     (a) Term. No Option shall be  exercisable  after the expiration of ten (10)
years from the date it was granted.

     (b) Price.  The exercise price of each Incentive  Stock Option shall be not
less  than one  hundred  percent  (100%) of the Fair  Market  Value of the stock
subject to the Option on the date the Option is granted.  The exercise  price of
each Nonstatutory Stock Option shall be not less than eighty-five  percent (85%)
of the Fair  Market  Value of the stock  subject  to the  Option on the date the
Option is granted.

     (c)  Consideration.  The purchase  price of stock  acquired  pursuant to an
Option  shall be paid,  to the  extent  permitted  by  applicable  statutes  and
regulations,  either (i) in cash at the time the Option is exercised, or (ii) at
the  discretion of the Board or the  Committee,  at the time of the grant of the
Option, (A) by delivery to the Company of other common stock of the Company, (B)
according to a deferred payment or other arrangement (which may include, without
limiting the generality of the  foregoing,  the use of other common stock of the
Company)  with the person to whom the Option is granted or to whom the Option is
transferred  pursuant  to  subsection  6(d),  or (C) in any other  form of legal
consideration  that may be acceptable to the Board.  In the case of any deferred
payment  arrangement,  interest  shall be payable at least annually and shall be
charged at the minimum  rate of interest  necessary  to avoid the  treatment  as
interest, under any applicable provisions of the Code, of any amounts other than
amounts  stated  to  be  interest  under  the  deferred   payment   arrangement.
Notwithstanding  anything to the foregoing,  the "par value" of the common stock
may not be paid by deferred payment.

     (d)  Transferability.  An Incentive  Stock Option shall not be transferable
except  by will  or by the  laws of  descent  and  distribution,  and  shall  be
exercisable during the lifetime of the person to whom the Incentive Stock Option
is granted only by such person. A Nonstatutory


                                       8.
<PAGE>


Stock Option may be transferred to the extent provided in the Option  Agreement;
provided that if the Option  Agreement does not expressly permit the transfer of
a  Nonstatutory  Stock  Option,  the  Nonstatutory  Stock  Option  shall  not be
transferable except by will, by the laws of descent and distribution or pursuant
to a domestic  relations order  satisfying the  requirements of Rule 16b-3,  and
shall be  exercisable  during the  lifetime  of the person to whom the Option is
granted only by such person or any transferee  pursuant to a domestic  relations
order.  Notwithstanding the foregoing,  the person to whom the Option is granted
may, by delivering written notice to the Company,  in a form satisfactory to the
Company, designate a third party who, in the event of the death of the Optionee,
shall thereafter be entitled to exercise the Option.

     (e) Vesting.  The total number of shares of stock subject to an Option may,
but need not, be allotted in periodic  installments (which may, but need not, be
equal).  The Option  Agreement may provide that from time to time during each of
such  installment  periods,  the  Option may become  exercisable  ("vest")  with
respect  to some  or all of the  shares  allotted  to  that  period,  and may be
exercised  with  respect to some or all of the shares  allotted  to such  period
and/or any prior period as to which the Option  became  vested but was not fully
exercised.  The Option may be subject to such other terms and  conditions on the
time or times when it may be  exercised  (which may be based on  performance  or
other  criteria)  as the  Board may deem  appropriate.  The  provisions  of this
subsection  6(e) are  subject to any Option  provisions  governing  the  minimum
number of shares as to which an Option may be exercised.

     (f) Securities Law Compliance. The Company may require any Optionee, or any
person to whom an Option is transferred under subsection 6(d), as a condition of
exercising any such Option, (1) to give written  assurances  satisfactory to the
Company as to the Optionee's  knowledge and experience in financial and business
matters and/or to employ a purchaser


                                       9.
<PAGE>



representative  reasonably  satisfactory to the Company who is knowledgeable and
experienced in financial and business matters,  and that he or she is capable of
evaluating, alone or together with the purchaser representative,  the merits and
risks of exercising the Option; and (2) to give written assurances  satisfactory
to the Company  stating that such person is acquiring  the stock  subject to the
Option for such  person's  own  account and not with any  present  intention  of
selling or otherwise distributing the stock. The foregoing requirements, and any
assurances given pursuant to such requirements,  shall be inoperative if (i) the
issuance of the shares upon the exercise of the Option has been registered under
a then currently  effective  registration  statement under the Securities Act of
1933,  as  amended  (the  "Securities  Act"),  or  (ii)  as  to  any  particular
requirement,  a  determination  is made by  counsel  for the  Company  that such
requirement  need not be met in the  circumstances  under  the  then  applicable
securities  laws. The Company may, upon advice of counsel to the Company,  place
legends  on stock  certificates  issued  under  the Plan as such  counsel  deems
necessary or appropriate  in order to comply with  applicable  securities  laws,
including, but not limited to, legends restricting the transfer of the stock.

     (g) Termination of Employment or Relationship as a Consultant. In the event
an Optionee's  Continuous Status as an Employee or Consultant  terminates (other
than upon the Optionee's death or disability),  the Optionee may exercise his or
her Option (to the extent that the  Optionee  was entitled to exercise it at the
date of  termination)  but only within such period of time ending on the earlier
of (i) the date  thirty  (30)  days  after  the  termination  of the  Optionee's
Continuous Status as an Employee or Consultant (or such longer or shorter period
specified in the Option  Agreement)  or (ii) the  expiration  of the term of the
Option as set forth in the Option Agreement. If, after termination, the Optionee
does not exercise his or her Option


                                      10.
<PAGE>


within the time specified in the Option  Agreement,  the Option shall terminate,
and the shares covered by such Option shall revert to and again become available
for issuance under the Plan.

     (h) Disability of Optionee. In the event an Optionee's Continuous Status as
an Employee or Consultant  terminates as a result of the Optionee's  disability,
the Optionee may exercise his or her Option (to the extent that the Optionee was
entitled to exercise it at the date of termination), but only within such period
of time  ending  on the  earlier  of (i) the date one (1)  year  following  such
termination  (or  such  longer  or  shorter  period   specified  in  the  Option
Agreement), or (ii) the expiration of the term of the Option as set forth in the
Option Agreement.  If, at the date of termination,  the Optionee is not entitled
to exercise his or her entire Option,  the shares  covered by the  unexercisable
portion of the Option shall revert to and again  become  available  for issuance
under the Plan. If, after termination, the Optionee does not exercise his or her
Option within the time specified  herein,  the Option shall  terminate,  and the
shares  covered by such Option shall revert to and again  become  available  for
issuance under the Plan.

     (i) Death of Optionee.  In the event of the death of an Optionee during, or
within a period  specified in the Option Agreement after the termination of, the
Optionee's  Continuous  Status as an Employee or  Consultant,  the Option may be
exercised (to the extent the Optionee was entitled to exercise the Option at the
date of death) by the Optionee's  estate,  by a person who acquired the right to
exercise  the Option by  bequest or  inheritance  or by a person  designated  to
exercise the option upon the Optionee's  death pursuant to subsection  6(d), but
only  within the period  ending on the  earlier  of (i) the date  eighteen  (18)
months  following the date of death (or such longer or shorter period  specified
in the Option  Agreement),  or (ii) the expiration of the term of such Option as
set forth in the Option Agreement. If, at the time of


                                      11.
<PAGE>

death,  the Optionee was not entitled to exercise his or her entire Option,  the
shares  covered by the  unexercisable  portion of the Option shall revert to and
again become  available for issuance under the Plan. If, after death, the Option
is not exercised within the time specified  herein,  the Option shall terminate,
and the shares covered by such Option shall revert to and again become available
for issuance under the Plan.

     (j) Early  Exercise.  The Option  may,  but need not,  include a  provision
whereby the  Optionee may elect at any time while an Employee or  Consultant  to
exercise  the Option as to any part or all of the  shares  subject to the Option
prior to the full vesting of the Option. Any unvested shares so purchased may be
subject  to a  repurchase  right  in  favor  of  the  Company  or to  any  other
restriction the Board determines to be appropriate.

     (k)  Withholding.  To  the  extent  provided  by  the  terms  of an  Option
Agreement,  the Optionee may satisfy any federal, state or local tax withholding
obligation relating to the exercise of such Option by any of the following means
or by a combination of such means: (1) tendering a cash payment; (2) authorizing
the Company to withhold  shares  from the shares of the common  stock  otherwise
issuable  to the  Optionee as a result of the  exercise  of the  Option;  or (3)
delivering to the Company owned and  unencumbered  shares of the common stock of
the Company. 

7. COVENANTS OF THE COMPANY.

     (a) During the terms of the Options,  the Company  shall keep  available at
all times the number of shares of stock required to satisfy such Options.

     (b) The Company  shall seek to obtain from each  regulatory  commission  or
agency having  jurisdiction  over the Plan such  authority as may be required to
issue and sell shares of stock upon exercise of the Options; provided,  however,
that this undertaking shall not require


                                      12.
<PAGE>


the Company to register  under the Securities Act either the Plan, any Option or
any stock issued or issuable  pursuant to any such Option.  If, after reasonable
efforts, the Company is unable to obtain from any such regulatory  commission or
agency the  authority  which  counsel for the Company  deems  necessary  for the
lawful  issuance and sale of stock under the Plan, the Company shall be relieved
from any  liability  for  failure to issue and sell stock upon  exercise of such
Options  unless and until such  authority is obtained.


8.   USE OF PROCEEDS FROM STOCK.

     Proceeds  from the sale of  stock  pursuant  to  Options  shall  constitute
general funds of the Company.

9.   MISCELLANEOUS.

     (a) The  Board  shall  have the  power to  accelerate  the time at which an
Option may first be  exercised  or the time  during  which an Option or any part
thereof will vest pursuant to subsection 6(e), notwithstanding the provisions in
the  Option  stating  the time at which it may  first be  exercised  or the time
during which it will vest.

     (b)  Neither an  Optionee  nor any person to whom an Option is  transferred
under subsection 6(d) shall be deemed to be the holder of, or to have any of the
rights of a holder with respect to, any shares subject to such Option unless and
until such person has  satisfied  all  requirements  for  exercise of the Option
pursuant to its terms.

     (c)  Nothing  in the Plan or any  instrument  executed  or  Option  granted
pursuant  thereto  shall confer upon any Employee or  Consultant or Optionee any
right to continue in the employ of the Company or any  Affiliate (or to continue
acting  as a  Consultant)  or  shall  affect  the  right of the  Company  or any
Affiliate to terminate  the  employment or  relationship  as a Consultant of any
individual with or without cause.


                                      13.
<PAGE>

     (d) To the extent that the aggregate  Fair Market Value  (determined at the
time of grant) of stock  with  respect  to which  Incentive  Stock  Options  are
exercisable  for the first time by any Optionee  during any calendar  year under
the Plan and all other stock plans of the Company and its Affiliates exceeds one
hundred  thousand  dollars  ($100,000),  the Options or portions  thereof  which
exceed such limit  (according to the order in which they were granted)  shall be
treated as Nonstatutory Stock Options.

10.  ADJUSTMENTS UPON CHANGES IN STOCK.

     (a) If any change is made in the stock  subject to the Plan,  or subject to
any Option (through  merger,  consolidation,  reorganization,  recapitalization,
stock dividend,  dividend in property other than cash, stock split,  liquidating
dividend,  combination  of  shares,  exchange  of  shares,  change in  corporate
structure  or  otherwise),  the  Plan  will  be  appropriately  adjusted  in the
class(es)  and  maximum  number  of  shares  subject  to the  Plan  pursuant  to
subsection  4(a) and the maximum number of shares subject to award to any person
during any  twelve  (12) month  period  pursuant  to  subsection  5(c),  and the
outstanding  Options will be appropriately  adjusted in the class(es) and number
of shares and price per share of stock subject to such outstanding Options.

     (b)  In  the  event  of:  (1)  a   dissolution,   liquidation  or  sale  of
substantially all of the assets of the Company; (2) a merger or consolidation in
which the Company is not the surviving  corporation;  or (3) a reverse merger in
which the Company is the surviving  corporation  but the shares of the Company's
common  stock  outstanding  immediately  preceding  the merger are  converted by
virtue of the merger  into other  property,  whether in the form of  securities,
cash or  otherwise,  then to the extent  permitted  by  applicable  law: (i) any
surviving  corporation  shall assume any Options  outstanding  under the Plan or
shall substitute similar Options for those


                                      14.
<PAGE>


outstanding  under the Plan, or (ii) such Options  shall  continue in full force
and effect. In the event any surviving corporation refuses to assume or continue
such Options,  or to substitute  similar options for those outstanding under the
Plan, then, with respect to Options held by persons then performing  services as
Employees  or  Consultants,  the time during which such Options may be exercised
shall be accelerated  and the Options  terminated if not exercised prior to such
event. 

11.  AMENDMENT OF THE PLAN AND OPTIONS.

     (a) The  Board at any  time,  and from  time to time,  may  amend the Plan.
However,  except as provided in Section 10 relating to adjustments  upon changes
in stock, no amendment shall be effective unless approved by the stockholders of
the  Company to the extent  stockholder  approval is  necessary  for the Plan to
satisfy the requirements of Section 422 of the Code, Rule 16b-3 or any Nasdaq or
securities exchange listing requirements.

     (b) The Board may in its sole discretion  submit any other amendment to the
Plan for stockholder approval,  including, but not limited to, amendments to the
Plan intended to satisfy the  requirements of Section 162(m) of the Code and the
regulations  promulgated thereunder regarding the exclusion of performance-based
compensation  from the limit on corporate  deductibility of compensation paid to
certain executive officers.

     (c) It is expressly  contemplated  that the Board may amend the Plan in any
respect the Board deems  necessary or advisable  to provide  Optionees  with the
maximum benefits provided or to be provided under the provisions of the Code and
the  regulations  promulgated  thereunder  relating to Incentive  Stock  Options
and/or to bring the Plan and/or  Incentive  Stock Options  granted under it into
compliance therewith.


                                      15.
<PAGE>


     (d) Rights and obligations under any Option granted before amendment of the
Plan shall not be impaired by any  amendment  of the Plan unless (i) the Company
requests  the consent of the person to whom the Option was granted and (ii) such
person consents in writing.

     (e) The  Board at any time,  and from time to time,  may amend the terms of
any one or more  Options;  provided,  however,  that the rights and  obligations
under any Option  shall not be  impaired  by any such  amendment  unless (i) the
Company  requests  the  consent of the person to whom the Option was granted and
(ii) such person consents in writing.

12.  TERMINATION OR SUSPENSION OF THE PLAN.

     (a) The Board may suspend or terminate the Plan at any time.  Unless sooner
terminated,  the Plan shall terminate on August 26, 2005,  which shall be within
ten (10) years from the date the Plan is adopted by the Board or approved by the
stockholders  of the Company,  whichever  is earlier.  No Options may be granted
under the Plan while the Plan is suspended or after it is terminated.

     (b) Rights and  obligations  under any Option  granted while the Plan is in
effect shall not be impaired by suspension or  termination  of the Plan,  except
with the  consent of the person to whom the Option was  granted. 

13.  EFFECTIVE DATE OF PLAN.

     The Plan shall become  effective as determined by the Board, but no Options
granted  under the Plan  shall be  exercised  unless and until the Plan has been
approved by the  stockholders  of the Company,  which  approval  shall be within
twelve  (12)  months  before or after the date the Plan is adopted by the Board,
and, if required,  an appropriate  permit has been issued by the Commissioner of
Corporations of the State of California.


                                      16.
<PAGE>

                               DIONEX CORPORATION

                        1988 DIRECTORS' STOCK OPTION PLAN

                     (As Amended and Restated July 28, 1997)

1.   PURPOSE

     (a) The purpose of the 1988 Directors' Stock Option Plan (the "Plan") is to
provide  a means by which  each  director  of  DIONEX  CORPORATION,  a  Delaware
corporation (the "Company"),  who is not otherwise an employee of the Company or
any Affiliate as defined in  subparagraph  1(b), and has not been an employee of
the Company or any Affiliate for all or part of the preceding  fiscal year (each
such person  being  referred to as a  "Non-Employee  Director")  may be given an
opportunity to purchase stock of the Company.

     (b) The word  "Affiliate" as used in the Plan means any parent  corporation
or subsidiary  corporation of the Company as those terms are defined in Sections
424(e) and (f),  respectively,  of the Internal Revenue Code of 1986, as amended
(the "Code").

     (c) The  Company,  by means of the Plan,  seeks to retain the  services  of
persons now serving as  Non-Employee  Directors  of the  Company,  to secure and
retain the  services  of persons  capable  of serving in such  capacity,  and to
provide  incentives for such persons to exert maximum efforts for the success of
the Company.

     (d) The  Company  intends  that the  options  issued  under the Plan not be
incentive  stock  options  as that term is used in Section  422 of the Code.  

2.   ADMINISTRATION

     (a) The Plan shall be  administered by the Board of Directors (the "Board")
of the  Company  unless  and  until  the  Board  delegates  administration  to a
committee,  as  provided  in  subparagraph  2(c).  Whether  or not the Board has
delegated administration, the Board shall have


                                       1.
<PAGE>


the final power to determine  all  questions of policy and  expediency  that may
arise in the administration of the Plan.

     (b) The Board shall have the power,  subject to and within the  limitations
of, the express provisions of the Plan:

          (1) To construe and interpret  the Plan and options  granted under it,
     and  to  establish,  amend,  and  revoke  rules  and  regulations  for  its
     administration.  The Board, in the exercise of this power,  may correct any
     defect,  omission,  or inconsistency in the Plan or in any option agreement
     or option grant form under the Plan, in a manner and to the extent it shall
     deem necessary or expedient to make the Plan fully effective.

          (2) To amend the Plan as provided in paragraph 11.

          (3) Generally, to exercise such powers and to perform such acts as the
     Board deems  necessary or  expedient  to promote the best  interests of the
     Company.

     (c) The  Board  may  delegate  administration  of the  Plan to a  committee
composed  of not fewer than two (2) members of the Board (the  "Committee").  If
administration  is  delegated  to a  Committee,  the  Committee  shall have,  in
connection with the administration of the Plan, the powers theretofore possessed
by the Board, subject,  however, to such resolutions,  not inconsistent with the
provisions  of the Plan,  as may be adopted from time to time by the Board.  The
Board  may  abolish  the  Committee  at any time and  revest  in the  Board  the
administration of the Plan. 

3.   SHARES SUBJECT TO THE PLAN

     (a) Subject to the provisions of paragraph 10 relating to adjustments  upon
changes in stock,  the stock that may be sold pursuant to options  granted under
the Plan shall not exceed


                                       2.
<PAGE>

in the aggregate one hundred fifty  thousand  (150,000)  shares of the Company's
common stock.  If any option  granted under the Plan shall for any reason expire
or otherwise  terminate  without  having been  exercised in full,  the stock not
purchased under such option shall again become available for the Plan.

     (b) The stock  subject  to the Plan may be  unissued  shares or  reacquired
shares, bought on the market or otherwise. 

4.   ELIGIBILITY

     Options shall be granted only to Non-Employee Directors of the Company.

5.   NON-DISCRETIONARY GRANTS

     (a)  Each  Non-Employee  Director  who  serves  on the  Company's  Board of
Directors on the date of initial approval of the Plan by the stockholders of the
Company in 1988 (the "Adoption  Date") shall  automatically be granted under the
Plan,  without  further  action by the  Company,  the  Board,  or the  Company's
stockholders, an option to purchase ten thousand (10,000) shares of common stock
of the Company (subject to adjustment as provided in paragraph 10 hereof) on the
terms and conditions set forth herein.

     (b) Each  person  who is elected  for the first  time to be a  Non-Employee
Director  after  the  Adoption  Date  shall,  on the date of his or her  initial
election as a Non-Employee Director by the Board or stockholders of the Company,
automatically  be granted an option to purchase ten thousand  (10,000) shares of
the  Company's  common stock  (subject to adjustment as provided in paragraph 10
hereof) upon the terms and conditions set forth herein.

     (c) On October 21 of each year (or the next  business  day should such date
be a legal holiday),  commencing October 21, 1989 and ending on October 21, 1996
(inclusive), and


                                       3.
<PAGE>


thereafter on the date of each annual meeting of stockholders of the Company, an
option to purchase two thousand  (2,000)  shares of the  Company's  common stock
(subject to adjustment  as provided in paragraph 10 hereof) shall  automatically
be granted to each person who (i) is at that time a Non-Employee  Director (and,
in the case of options  granted after 1996, has been re- elected to the Board by
the stockholders on such date),  (ii) has already received an option to purchase
10,000 shares of common stock of the Company pursuant to paragraphs 5(a) or 5(b)
hereof,  and (iii) has served  continuously  as a Non-Employee  Director for the
entire preceding fiscal year. 

6. OPTION PROVISIONS

     Each option  granted under the Plan shall  contain the following  terms and
conditions  (through  incorporation  of  provisions  hereof by  reference in the
option or otherwise):

     (a) The term of each option  shall be five (5) years from the date  granted
(the "Expiration Date"). Notwithstanding the foregoing, if an optionee's service
as a  Non-Employee  Director  or,  subsequently,  as an  employee of the Company
terminates for any reason or for no reason,  the option(s) held by such optionee
shall  terminate  on the  earlier  of the  Expiration  Date or thirty  (30) days
following the date of termination  of service;  provided,  however,  that (i) if
such  termination  of service is due to the  optionee's  death or permanent  and
total  disability  (within  the  meaning  of  Section  422(c)(6)  of  the  Code)
("disability"), the option shall terminate on the earlier of the Expiration Date
or twelve (12) months  following the date of the optionee's death or disability,
or (ii) if exercise of the option within thirty (30) days after such termination
of service  would  result in liability  under  section  16(b) of the  Securities
Exchange Act of 1934, as amended,  the option shall  terminate on the earlier of
(A) the Expiration Date of the option,


                                       4.
<PAGE>



(B) the tenth (10th) day after the last date upon which exercise would result in
such liability, or (C) six (6) months and ten (10) days after the termination of
service with the Company.

     (b) The exercise  price of each option shall be one hundred  percent (100%)
of the fair  market  value of the stock  subject to such option on the date such
option is granted.

     (c) The optionee may elect to make payment of the purchase  price of common
stock   acquired  upon  exercise  of  an  option  under  one  of  the  following
alternatives:  (1) payment of the exercise  price in cash at the time the option
is exercised;  (2) provided  that at the time of exercise the  Company's  common
stock is  publicly  traded  and quoted  regularly  in The Wall  Street  Journal,
payment by  delivery  of shares of common  stock of the  Company  that have been
owned by the  optionee  for at least six (6)  months and that are owned free and
clear of any liens, claims,  encumbrances,  or security interests,  which common
stock  shall be  valued at fair  market  value on the date of  exercise;  or (3)
payment by a combination  of the methods of payment  specified in  subparagraphs
6(c)(1) and 6(c)(2) above.

     (d) An option  shall not be  transferable  except by will or by the laws of
descent and  distribution,  and shall be exercisable  during the lifetime of the
person  to whom the  option  is  granted  only by such  person  or by his or her
guardian or legal representative. The optionee may, by delivering written notice
to the Company,  in a form satisfactory to the Company,  designate a third party
who, in the event of the death of the optionee,  shall thereafter be entitled to
exercise the option.

     (e) (1) An option  shall  vest with  respect to each  optionee  in four (4)
equal  annual  installments  commencing  on the date one year  after the date of
grant,  provided  that the  optionee  has,  during the entire year prior to such
vesting date, continuously served as a Non-Employee


                                       5.
<PAGE>

Director  or as an  employee of the  Company or any  Affiliate  of the  Company,
whereupon  such option shall become fully  exercisable  in  accordance  with its
terms  with  respect  to  that  portion  of  the  shares   represented  by  that
installment.

     (2)  In  the  event  of  the  termination  of an  optionee's  service  as a
Non-Employee  Director or as an employee of the Company or any  Affiliate of the
Company,  options held by such optionee may be exercised  only as to that number
of shares as to which such options were  exercisable  on the date of termination
of such service under the provisions of Section  6(e)(1) above.  Notwithstanding
the  foregoing,  however,  in  the  event  such  service  terminates  due  to an
optionee's death or disability, such options shall become exercisable in full in
accordance  with  their  terms  and  without  regard to their  original  vesting
schedule.

     (f) The Company may require any  optionee,  or any person to whom an option
is transferred  under  subparagraph  6(d), as a condition of exercising any such
option:  (1) to give written  assurances  satisfactory  to the Company as to the
optionee's  knowledge and experience in financial and business matters;  and (2)
to give written  assurance  satisfactory to the Company stating that such person
is acquiring  the stock  subject to the option for such person's own account and
not with any present  intention of selling or otherwise  distributing the stock.
These  requirements,  and any assurances  given  pursuant to such  requirements,
shall be  inoperative if (i) the issuance of the shares upon the exercise of the
option  has  been  registered  under  a then  currently  effective  registration
statement under the Securities Act of 1933, as amended (the  "Securities  Act"),
or (ii) as to any particular requirement, a determination is made by counsel for
the Company that such requirement need not be met in the circumstances under the
then applicable securities laws.


                                       6.
<PAGE>


7.   COVENANTS OF THE COMPANY

     (a) During the terms of the  options  granted  under the Plan,  the Company
shall keep  available at all times the number of shares of common stock required
to satisfy such options.

     (b) The Company  shall seek to obtain from each  regulatory  commission  or
agency having  jurisdiction  over the Plan such  authority as may be required to
issue and sell shares of common stock upon exercise of the options granted under
the Plan; provided, however, that this undertaking shall not require the Company
to register  under the  Securities Act either the Plan, any option granted under
the Plan,  or any stock issued or issuable  pursuant to any such option.  If the
Company is unable to obtain from any such  regulatory  commission  or agency the
authority  for which  counsel for the  Company  deems  necessary  for the lawful
issuance and sale of common stock under the Plan,  the Company shall be relieved
from any  liability  for failure to issue and sell common stock upon exercise of
such options  unless and until such  authority  is obtained.  

8.   USE OF PROCEEDS FROM STOCK

     Proceeds from the sale of stock pursuant to options  granted under the Plan
shall constitute general funds of the Company.

9.   MISCELLANEOUS

     (a)  Neither an  optionee  nor any person to whom an option is  transferred
under  subparagraph  6(d) hereof shall be deemed to be the holder of, or to have
any of the rights of a holder with respect to, any shares subject to such option
unless and until such person has satisfied all  requirements for exercise of the
option pursuant to its terms.

     (b)  Throughout  the term of any option  granted  pursuant to the Plan, the
Company  shall make  available to the holder of such option,  not later than one
hundred twenty (120) days


                                       7.
<PAGE>


after the close of each of the  Company's  fiscal  years during the option term,
upon written request, such financial and other information regarding the Company
as comprises the annual report to the  stockholders of the Company  provided for
in the Bylaws of the Company and such other information regarding the Company as
the holders of such option may reasonably request.

10.  ADJUSTMENTS UPON CHANGES IN STOCK

     (a) If any  change is made in the  common  stock  subject  to the Plan,  or
subject to any option  granted  under the Plan (through  merger,  consolidation,
reorganization,  recapitalization,  stock  dividend,  dividend in property other
than cash, stock split, liquidating dividend, combination of shares, exchange of
shares, change in corporate structure,  or otherwise),  the Plan and outstanding
options will be  appropriately  adjusted in the class(es) and maximum  number of
shares  subject to the Plan and the class(es) and number of shares and price per
share of stock subject to outstanding options.

     (b) In the event of (1) a dissolution, liquidation or sale of substantially
all of the assets of the  Company;  (2) a merger or  consolidation  in which the
Company  is  not  the   surviving   corporation;   or  (3)  any  other   capital
reorganization (including a reverse merger in which the Company is the surviving
corporation) in which more than fifty percent (50%) of the shares of the Company
entitled to vote are exchanged for or converted into other property,  whether in
the form of  securities,  cash or  otherwise,  then to the extent  permitted  by
applicable  law:  (i)  any  surviving   corporation  shall  assume  any  options
outstanding  under  the Plan or  shall  substitute  similar  options  for  those
outstanding  under the Plan, or (ii) such options  shall  continue in full force
and effect. In the event any surviving corporation refuses to assume or continue
such options,  or to substitute  similar options for those outstanding under the
Plan, then, with respect


                                       8.



to options held by persons then performing  services as a Non-Employee  Director
or as an employee of the  Company,  the time  during  which such  options may be
exercised shall be accelerated and the options terminated if not exercised prior
to such  event.  Notwithstanding  the  foregoing,  no option  may be  terminated
pursuant to this provision unless and until ten (10) days written notice of such
termination  has been given to the holder of an option to be so terminated.  

11.  AMENDMENT OF THE PLAN

     (a) The Board at any time, and from time to time, may amend the Plan.

     (b) Rights and obligations under any option granted before amendment of the
Plan shall not be altered or impaired by any amendment of the Plan,  except with
the consent of the person to whom the option was  granted.  

12.  TERMINATION OR SUSPENSION OF THE PLAN

     (a) The Board may suspend or terminate the Plan at any time.  Unless sooner
terminated,  the Plan shall  terminate at the time that all shares  reserved for
issuance  under the Plan have been issued.  No options may be granted  under the
Plan while the Plan is suspended or after it is terminated.

     (b) Rights and  obligations  under any option  granted while the Plan is in
effect  shall not be altered or impaired by  suspension  or  termination  of the
Plan, except with the consent of the person to whom the option was granted.

13.  EFFECTIVE DATE OF PLAN

     The Plan shall become  effective  upon  adoption by the Board of Directors,
subject to the condition that the Plan be approved by the vote of the holders of
a  majority  of the  shares of the  Company  represented  and voting at the next
special or annual meeting of stockholders of the


                                       9.
<PAGE>

Company.  No option  granted  under the Plan shall be exercised  or  exercisable
unless and until the condition of this Paragraph 13 has been met.















                                      10.
<PAGE>

                               DIONEX CORPORATION

                    PROXY SOLICITED BY THE BOARD OF DIRECTORS
                     FOR THE ANNUAL MEETING OF STOCKHOLDERS

                         TO BE HELD ON OCTOBER 23, 1997

     The  undersigned  hereby appoints A. BLAINE BOWMAN and MICHAEL W. POPE, and
each of them,  as attorneys and proxies of the  undersigned,  with full power of
substitution,  to vote all of the shares of stock of Dionex Corporation that the
undersigned  may be entitled to vote at the Annual  Meeting of  Stockholders  of
Dionex  Corporation  to be  held  at  Dionex  Corporation,  501  Mercury  Drive,
Sunnyvale,  California 94086 on Thursday,  October 23, 1997, at 9:00 a.m., local
time, and at any and all postponements,  continuations and adjournments thereof,
with all powers that the undersigned would possess if personally  present,  upon
and in respect of the  following  matters and in  accordance  with the following
instructions,  with discretionary authority as to any and all other matters that
may properly come before the meeting.

     UNLESS A CONTRARY DIRECTION IS INDICATED,  THIS PROXY WILL BE VOTED FOR ALL
NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSALS 2, 3 AND 4, AS MORE SPECIFICALLY
DESCRIBED IN THE PROXY STATEMENT.  IF SPECIFIC INSTRUCTIONS ARE INDICATED,  THIS
PROXY WILL BE VOTED IN ACCORDANCE THEREWITH.

THE BOARD OF DIRECTORS  RECOMMENDS  A VOTE FOR THE NOMINEES FOR DIRECTOR  LISTED
BELOW.

PROPOSAL 1: To elect  directors to hold office until the next Annual  Meeting of
            Stockholders and until their successors are elected.

|_|  FOR all nominees listed below                |_|      WITHHOLD AUTHORITY to
     (except as marked to the contrary                     vote for all nominees
     below).                                               listed below.

Nominees: David L. Anderson, James F. Battey, A. Blaine Bowman, B. J. Moore

To withhold authority to vote for any nominee(s), write such nominee(s)' name(s)
below

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                            (Continued on other side)


                                       1.
<PAGE>

                           (Continued from other side)

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 2, 3 AND 4.

PROPOSAL 2: To approve an amendment to the Dionex  Corporation Stock Option Plan
            to  increase  the  aggregate   number  of  shares  of  Common  Stock
            authorized for issuance under such plan by 400,000 shares.

         |_| FOR                |_| AGAINST                 |_| ABSTAIN

PROPOSAL 3: To approve an amendment to the 1988  Directors  Stock Option Plan to
            extend  the term of the plan to July  27,  2007 and to make  certain
            administrative changes.

         |_| FOR                |_| AGAINST                 |_| ABSTAIN

PROPOSAL 4: To ratify the  selection  of Deloitte & Touche LLP as the  Company's
            independent auditors for its fiscal year ending June 30, 1998.

         |_| FOR                |_| AGAINST                 |_| ABSTAIN


DATED ________, 1997                           _________________________________
                                                        SIGNATURE(S)

                                        Please sign exactly as your name appears
                                        hereon.  If the stock is  registered  in
                                        the names of two or more  persons,  each
                                        should sign. Executors,  administrators,
                                        trustees,          guardians         and
                                        attorneys-in-fact   should   add   their
                                        titles.  If  signer  is  a  corporation,
                                        please give full corporate name and have
                                        a duly authorized  officer sign, stating
                                        title.   If  signer  is  a  partnership,
                                        please  sign  in  partnership   name  by
                                        authorized person.

Please vote, date and promptly return this proxy in the enclosed return envelope
which is postage prepaid if mailed in the United States.


                                       2.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission